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 I
Abstract 
mRNA expression of the acute phase protein haptoglobin in blood 
and milk somatic cells and cellular localisation within the mammary 
gland of dairy cows 
The haptoglobin (Hp) concentration in blood and milk is increasingly discussed as a 
diagnostic marker for bovine mastitis. This acute phase protein is mainly synthesised in the 
liver, however, Hp mRNA was also discovered in tissue homogenates of the bovine 
mammary gland. The aim of this study was to advance this finding by allocating Hp mRNA 
expression within the bovine mammary gland at the cellular level. Possible candidates are, 
firstly, cells of the mammary gland itself and, secondly, circulating leukocytes infiltrating the 
udder. The presence of the Hp mRNA in the latter cells was investigated by RT-PCR carried 
out with RNA extracted from bovine blood leukocytes as well as from milk somatic cells. In 
order to localise Hp mRNA expression at the cellular level within the mammary gland a 
protocol for in situ hybridisation was developed. Subsequently, this was applied to bovine 
mammary tissues infected with Escherichia coli (E. coli) or Staphylococcus aureus (Staph. 
aureus) by intracisternal inoculation 0, 6, 12 or 24 h pre-slaughter. In addition, blood and milk 
samples from these cows were analysed for the concentration of Hp protein collected during 
the 24 h infection and immediately pre-slaughter, respectively. In comparison to cattle, human 
leukocytes and mammary gland tissue were evaluated for Hp mRNA by RT-PCR, because of 
existing, however contradicting evidence on Hp expression in man.  
The results demonstrate that Hp mRNA is present in bovine leukocytes as well as milk 
somatic cells. Within the bovine mammary gland Hp mRNA expression could generally be 
assigned to the alveolar epithelial cells. In addition, E. coli pathogens caused a marked 
upregulation of Hp mRNA expression within hours after start of infection, whereas Hp 
mRNA expression in response to Staph. aureus infection appeared unchanged during the 
initial 24 h post-infection. These differences in mRNA presence between the pathogen types 
were matched by Hp protein concentrations measured in blood and milk. In humans, Hp 
mRNA was also evident in the mammary gland and in 50% of the leukocytes samples tested. 
In conclusion, this study identified novel cellular sites of Hp mRNA expression in dairy cows 
and, thus, possible sources of the Hp protein found in milk. 
 II
Zusammenfassung 
mRNA Expression des Akute Phase Proteins Haptoglobin in Blut- 
und Milchzellen sowie zelluläre Lokalisation im Euter von 
Milchkühen 
Die Konzentration von Haptoglobin (Hp) in Blut und Milch wird als diagnostischer Marker 
für die Mastitis des Rindes zunehmend diskutiert. Dieses Akute Phase Protein wird 
hauptsächlich in der Leber synthetisiert, jedoch konnte Hp mRNA auch in Gewebehomo-
genaten der bovinen Milchdrüse nachgewiesen werden. Auf diesem Ergebnis aufbauend war 
das Ziel dieser Studie, die Hp mRNA Expression innerhalb der bovinen Milchdrüse auf 
zellulärer Ebene zuzuweisen. Dafür in Frage kommen einerseits Zellen der Milchdrüse selbst 
und andererseits Leukozyten, die aus dem Blut in das Euter einwandern. Um die Präsenz von 
Hp mRNA in den letztgenannten Zellen zu untersuchen, wurde mit RNA aus bovinen 
Blutleukozyten und aus Milchzellen eine RT-PCR durchgeführt. Zur zellulären Lokalisierung 
der Hp mRNA Expression in der Milchdrüse wurde ein Protokoll für eine in situ 
Hybridisierung entwickelt. Mit diesem Protokoll wurde anschließend Milchdrüsengewebe 
von Kühen untersucht, welches 0, 6, 12 oder 24 h vor der Schlachtung durch intrazisternale 
Applikation mit Escherichia coli (E. coli) oder Staphylococcus aureus (Staph. aureus) 
infiziert wurde. Zusätzlich wurde die Hp-Proteinkonzentration in Blut- und Milchproben 
gemessen, die diesen Kühen während der 24-stündigen Infektion bzw. unmittelbar vor der 
Schlachtung genommen worden waren. Im Vergleich zum Rind wurden wegen bereits 
bestehender, aber widersprüchlicher Angaben zur Hp Expression beim Menschen zudem 
Leukozyten und Milchdrüsengewebe des Menschen mittels RT-PCR auf Hp mRNA getestet. 
Die Ergebnisse zeigen, dass Hp mRNA in bovinen Leukozyten und Milchzellen vorhanden 
ist. Im Euter konnte die Hp mRNA Expression den Zellen des Alveolarepithels zugeordnet 
werden. Zusätzlich zeigte sich, dass in diesen Epithelzellen E. coli Pathogene innerhalb von 
Stunden nach Beginn der Infektion einen deutlichen Anstieg der Hp mRNA Expression 
verursachten, wogegen diese Expression als Antwort auf die Staph. aureus Infektion in den 
ersten 24 h unverändert blieb. Ähnliche Unterschiede zwischen den Pathogentypen ergaben 
sich für die Hp Konzentrationen in Blut und Milch. Beim Menschen wurde Hp mRNA in der 
Brustdrüse und in 50 % der untersuchten Leukozytenproben nachgewiesen. Mit dem 
erstmaligen Nachweis von Hp mRNA Expression in den beschriebenen Zellen konnten somit 
mögliche Quellen von Hp Protein in der Milch identifiziert werden. 
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 1 Introduction 
The role of the acute phase protein haptoglobin (Hp) during infection of the mammary gland 
in cattle has been investigated in recent years with increasing interest. The chapters of the 
introduction below provide a brief overview of the current knowledge of Hp in general and 
more specifically its involvement during bovine mastitis. Finally, the aims of this study are 
defined. 
1.1 Haptoglobin (Hp) 
1.1.1 Occurrence and sites of haptoglobin synthesis 
Hp is mainly found in plasma, but is also present in many other body fluids in mammals such 
as milk, urine, cord serum, cerebrospinal fluid, amniotic fluid and saliva (Katnik and 
Dobryszycka, 1990; Hiss et al., 2003; Hiss et al., 2004).  
Liver is the primary site of Hp synthesis (Miller et al., 1951). In addition, Hp expression has 
been reported in a variety of extrahepatic tissues. Hp mRNA could be detected in spleen, 
thymus, heart, lung and kidney of the rat after lipopolysaccharide (LPS) challenge 
(Kalmovarin et al., 1991). Similarly, Hp mRNA was also found in murine adipocytes at a 
basal level and at elevated levels after LPS challenge (Friedrichs et al., 1995). These 
researchers estimated the basal level of Hp mRNA in adipose tissue to be 10-15% of the 
levels in liver. Moreover, murine lung epithelial cells express Hp mRNA (Yang et al., 2000). 
There is also evidence of Hp mRNA in the reproductive tract. Hp mRNA expression was 
shown in rabbit oviductal tissue from 6 h post-conception to day 3 and in the uterus on days 5 
and 6 post-conception (Herrler et al., 2004), in human endometrium (Sharpe-Timms et al., 
2000) and in bovine oviduct (Lavery et al., 2004). In addition, macrophages and eosinophils 
as well as epidermal keratinocytes express Hp in humans (Yang et al., 2000; Li et al., 2005). 
Finally, Hp mRNA was identified in the mammary gland of cows (Hiss et al., 2004). 
Summarising for cattle, liver, oviduct and mammary gland are the only sites currently 
recognised of Hp mRNA expression.  
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1.1.2 Structure and phenotypes 
Hp is a α2-glycoprotein and is synthesised as a single chain polypeptide, which is cleaved into 
an amino-terminal α-chain and a carboxy-terminal β-chain (Bowman and Kurosky, 1982). 
There are two major α chains, a shorter and a longer variation, designated as α1 and α2 chains, 
respectively. Sequence studies showed that the Hp α2 allele arose from a partial gene 
duplication of the Hp α1 allele (Smithies et al., 1962). The basic Hp isoform, Hp1-1, is a 
monomer in which two α1β Hp molecules are linked by a single disulfide bond through their 
respective α1-chains (Smithies et al., 1962). This phenotype is found in most mammals except 
the Bovidae and Cervidae families. They exhibit the Hp2-2 type, a polymer of the α2β Hp 
molecule (Travis and Sanders, 1972; Busby and Travis, 1978). Humans are the only species 
known to display phenotypic heterogeneity. Besides the homozygous Hp1-1 and Hp2-2 type, 
they can be heterozygous for the α chain locus giving rise to the Hp2-1 type (Smithies and 
Walker, 1956). Hp2-1 consists of two α1β subunits flanking a α2β polymer. Eckersall and 
Conner (1990) assessed the molecular mass of the bovine Hp molecule and the according α2 
and β chains as > 1000 kDa, 16 kDa and 40 kDa, respectively, thus confirming a similarity in 
molecular size of the two subunits to the human Hp2-2 types (Travis and Sanders, 1972). 
1.1.3 Physiological functions of Hp 
The main physiological tasks assigned to Hp are transport and immunomodulatory properties. 
The best recognised function of haptoglobin is to bind free haemoglobin (Hb) and to transport 
Hb to the liver. More specifically, after the release of Hb into plasma, a physiological 
phenomenon associated with haemolysis or apoptosis of erythrocytes, Hp can attach to Hb by 
non-covalent binding at a ratio of 1:1 (Fraser and Smith, 1971). This Hp-Hb complex cannot 
pass the glomerular filtration in the kidney due to its large molecular size, thereby preventing 
renal losses of the small Hb molecule (Fagoonee et al., 2005). Instead, the Hp-Hb complex is 
metabolised by CD163-positive monocytes/macrophages making the Hb-iron available for 
new Hb synthesis (Kristiansen et al., 2001). Besides the recycling of Hb-iron, the formation of 
the Hp-Hb complex possesses two additional benefits. On the one hand, Hp has a 
bacteriostatic effect by hampering the iron requiring process of bacterial replication as shown 
in rats inoculated with pathogenic Escherichia coli (E. coli) (Eaton et al., 1982). On the other 
hand, Hp was assigned an anti-oxidative role by inhibiting Hb-driven free radical oxidative 
tissue damage (Miller et al., 1997).  
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Another important property associated with Hp is the modulation of the inflammatory 
response by acting on different immune cells. Hp suppresses the production of pro-
inflammatory, but not anti-inflammatory cytokines in human monocytes and inhibits the 
respiratory burst activity of human neutrophils (Oh et al., 1990; Arredouani et al., 2005). In 
addition, lymphocyte proliferation normally occurring after stimulation with concanavalin A 
or LPS in rabbits was reduced in the presence of Hp (Baseler and Burrell, 1983). In addition, 
Hp appears to act as a systemic regulator of dendritic cell function by preventing functional 
maturation of epidermal Langerhans cells, i.e. their transformation to cells capable of 
presenting antigens to T-cells (Xie et al., 2000). 
Finally, there is evidence that Hp stimulates angiogenesis, thus supporting tissue repair under 
inflammatory conditions (Cid et al., 1993).  
1.2 Haptoglobin – an acute phase protein 
1.2.1 The acute phase reaction and acute phase proteins 
Hp belongs to the group of Acute Phase Proteins (APPs) which come into play during the 
Acute Phase Reaction (APR). The APR was defined for the first time in 1941 by Abernethy 
and Avery (1941) and describes the organism's response to injury, infection or trauma of a 
tissue as well as to immunological disorders e.g. rheumatoid arthritis. It comprises a complex 
cascade of reactions to prevent further tissue damage, eliminate any infective organisms and 
enhance the healing process in order to restore homeostasis. It is initiated by macrophages of 
the affected tissue or by blood monocytes which release a wide range of mediators including 
cytokines. These cytokines act on fibroblasts and endothelial cells in the near vicinity causing 
a second release of cytokines. Only this second wave of cytokines triggers the actual cascade 
of complex reactions as part of the APR occurring locally and systemically. Locally, 
cytokines mediate leukocyte recruitment, in particular neutrophils and mononuclear cells, to 
the sites of inflammation. Systemically, they act on the immune system, bone marrow, brain 
and liver, and the reaction comprises the generation of a febrile response, an increase in 
adrenocorticotropic hormone (ACTH) secretion, leukocytosis and alteration of the hepatic 
APP gene expression. This change of hepatic APP expression leads to increases as well as 
decreases of APP plasma concentrations dividing them into positive and negative APPs, 
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respectively (summarised according to the reviews of Heinrich et al. (1990) and Baumann and 
Gauldie (1994)). Since Hp is produced at elevated levels during the APR, it is categorised as a 
positive APP (Skinner et al., 1991; Dobryszycka, 1997). 
1.2.2 Cytokine control of APP synthesis  
The APP synthesis is controlled by cytokines as mentioned above. They act directly upon 
specific receptors of hepatocytes prompting APP production (Peters et al., 1997). APPs can be 
divided into two major categories according to their regulators: type 1 APP production is 
induced by interleukin (IL)-1 and tumour necrosis factor-alpha (TNF-α), whereas type 2 APP 
synthesis is elicited by IL-6 (Baumann and Gauldie, 1994). IL-6 is believed to be the primary 
stimulator of most APP genes, however, there is evidence that IL-1 and TNF-α can amplify 
the effects of IL-6 (Heinrich et al., 1990). In cattle, IL-6 could be established as the principal 
regulator of Hp production in hepatocytes (Yoshioka et al., 2002); hence, it can be classified 
as type 2 APP in this species. Similarly, Hp is ranked as type 2 APP in man, however, as 
type 1 in the rat (Baumann and Gauldie, 1994). 
Induced by IL-6, the actual Hp gene transcription within a cell is mediated by signal 
transducers and activators of transcription proteins (STAT) of which STAT3 has been 
described as the main signalling protein in mice hepatocytes in vitro (Kim and Baumann, 
1997). After binding of IL-6 to its receptor, STAT3 is activated at the cytoplasmic side of the 
IL-6 receptor by phosphorylation. Once activated it translocates to the nucleus. In mice, the 
three main regulatory elements of the Hp gene promoter are two recognition sites for the 
transcription factor CCAAT/enhancer binding protein beta (C/EBPβ) flanking a STAT 
interaction site. Binding of STAT3 to this interaction site has been identified as the key 
upregulator of murine Hp gene transcription induced by IL-6, whereas binding of other STAT 
proteins, e.g. STAT5, exerts inhibitory effects (Kim and Baumann, 1997; Wang et al., 2001). 
Besides their direct regulatory effect, cytokines can also act via the pituitary-adrenal axis on 
APP production. They mediate an increased release of glucocorticoids by causing a higher 
secretion of ACTH during the APR. Glucocorticoids, in turn, enhance the APP production in 
hepatocytes on the one hand, and reduce the release of cytokines from monocytes and 
macrophages on the other hand (Heinrich et al., 1990). However, the effect on Hp expression 
in hepatocytes via this route appears low compared to the direct route (Marinkovic and 
Baumann, 1990). The signalling pathway of ACTH on the Hp promoter has yet to be fully 
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characterised; a direct glucocorticoid receptor binding site in the murine Hp promotor is 
suspected (Pajovic et al., 1994). 
1.2.3 Species specific APP response during APR  
Several plasma proteins are known as APPs, however, depending on the species the protein 
pattern of each single APP during the APR is highly varying. In cattle, Hp and serum 
amyloid A (SAA) are considered as the most prominent APPs, whereas C-reactive protein 
(CRP) is normally present in circulation and its concentration remains unchanged during an 
acute phase (Eckersall and Conner, 1988; Gronlund et al., 2003; Pedersen et al., 2003). In 
contrast, CRP is recognised as a major reactant in the pig together with pig-Map (pig major 
acute phase protein) and also Hp (Lampreave et al., 1994; Gonzalez-Ramon et al., 2000). In 
man, CRP besides SAA shows the highest increases during an APR, whereas Hp increases 
only moderately (Heinrich et al., 1990). Similarly in the dog, CRP is classified as a major 
APP, whereas in the rat, α2-macroglobulin and α1-acid glycoprotein are the APPs with the 
greatest increase of concentration during the APR (Eckersall and Conner, 1988; Heinrich et 
al., 1990). 
1.3 Haptoglobin as an indicator of mastitis and other 
disorders in cattle 
In healthy cattle, Hp blood concentrations have been described as low or even not detectable 
(Morimatsu et al., 1992; Eckersall et al., 2001), whereas numerous studies have reported 
pathological increases during the APR in response to mastitis and other disorders. In cases of 
mastitis, evaluating Hp not only in blood, but also in milk has recently been demonstrated to 
be beneficial. Hp concentration in milk appears to react with higher fold increases and earlier 
to intramammary infection than Hp concentration in blood. Hiss et al. (2004) found a 10-fold 
increase in blood Hp concentration and even a 150-fold increase in milk levels after 
intramammary inoculation with LPS compared to pre-challenge values; the Hp levels in milk 
from the control quarter remained unchanged. Likewise, Pedersen et al. (2003) identified an 
8-fold rise in milk Hp concentration as a result of an experimental inoculation into mammary 
gland quarters with Streptococcus uberis compared to pre-challenge and control quarter 
levels, but no change in serum levels. Another major mastitis pathogen is Staphyloccocus 
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aureus (Staph. aureus). Elevations of Hp blood and milk concentrations were observed in 
cows with experimental Staph. aureus mastitis, however, the increase was 20-fold in both 
fluids (Gronlund et al., 2003). During the subsequent chronic phase of the infection the 
elevation of the concentration of SAA in blood was more pronounced than Hp. This is in 
contrast to a later investigation by the same research group where Hp was detectable more 
often than SAA in serum samples from cows with natural chronic subclinical mastitis 
(Gronlund et al., 2005).  
Besides mastitis, the bovine Hp response during an APR induced by other disrupting incidents 
has also been investigated intensively. For example, prolonged transport of calves over two 
days significantly affected Hp blood levels (Murata and Miyamoto, 1993), and cows 
undergoing invasive surgery showed a 50-fold increase in their blood Hp concentrations 
(Morimatsu et al., 1992). Also experimental challenges with LPS or turpentine applied to 
cattle intravenously or subcutaneously elicited higher serum concentrations than pre-
challenge values (Conner et al., 1988; Jacobsen et al., 2004).  
All these cases demonstrate the substantial involvement of Hp during the bovine APR. More 
importantly, though, some researchers have made an attempt at establishing the diagnostic 
value of Hp by correlating the level of Hp concentration to the severity of the disease. Indeed, 
Godson et al. (1996) demonstrated in an experimental infection model for bovine respiratory 
disease that Hp could be detected in infected animals before the onset of clinical signs and 
that its concentration could be used as an indicator of disease severity. In contrast, other 
authors found that in the case of a respiratory disease Hp concentration is not correlated with 
severity (Wittum et al., 1996). Again in two other experimental studies already mentioned 
above, a dose-dependency of Hp serum levels was recognised after LPS or turpentine 
injection (Conner et al., 1988; Jacobsen et al., 2004). 
Particularly in the case of mastitis, considering it is the second major reason for dairy cows 
leaving the herd (Arbeitsgemeinschaft Deutscher Rinderzüchter, 2005), an objective and 
rapidly assessable indicator of the disease is desirable that allows the effective discrimination 
between healthy and diseased animals, preferably even quarters. In the event of naturally 
occurring clinical mastitis, serum Hp levels provided sensitivities and specificities for 
differentiating between healthy cows and cows affected by mastitis of 82% and 94%, 
respectively; for milk Hp the corresponding values were assessed at 86% and 100% 
(Eckersall et al., 2001). Analyses of Hp in milk from cows with naturally occurring 
subclinical mastitis yielded a sensitivity of 85% and a specificity of 94% (Hiss et al., 2005). 
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Gronlund et al. (2005) concluded from their above mentioned work with cows suffering of 
natural chronic subclinical mastitis that the absence of any detectable Hp as well as SAA in 
milk was a good indicator of healthy quarters.  
In summary, although some potential could be demonstrated, further refinements are clearly 
needed before Hp fulfils the requirements of a reliable indicator of disease, especially of 
inflammation in the bovine mammary gland. A more detailed knowledge of the physiological 
processes in healthy and infected mammary glands regarding the major bovine APP Hp might 
aid in advancing the diagnostic value of this APP for mastitis.  
Recently, the presence of Hp mRNA was verified in homogenates of bovine mammary glands 
(Hiss et al., 2004). Even an increase in the abundance of local Hp mRNA was triggered by 
LPS challenge into the quarter. This suggests that Hp protein is produced locally within the 
mammary gland to encounter bacterial invasion. The exact cell type expressing Hp could not 
be identified by the above method based on RNA from homogenates. Possible candidates are 
cells of the gland itself as well as immune cells known to infiltrate this organ in the healthy 
but particularly during the diseased state (Kehrli and Shuster, 1994). The elucidation of these 
two possibilities would further specify the results by Hiss et al. (2004). Human studies on Hp 
mRNA expression in leukocytes provide contradicting evidence: Wagner et al. (1996) found 
no Hp mRNA expression in the entire population of human peripheral blood leukocytes, 
whereas Yang et al. (2000) reported Hp mRNA in peripheral eosinophilic granulocytes. No 
information on Hp mRNA expression in mammary gland in any species other than cattle 
could be retrieved from the current literature. 
1.4 In situ hybridisation 
The localisation of Hp mRNA at the cellular level can be achieved by in situ hybridisation 
(ISH) applied to tissue sections. The general principle of this method is described here since it 
represented an integral part of this study. 
ISH is a technique that allows specific nucleic acid sequences to be directly localised in 
morphologically preserved chromosomes, cells or tissue. For this purpose, a labelled nucleic 
acid (probe) is generated which is specific for, but complementary to the target nucleic acid. 
This allows annealing of the two nucleic acids to form a double stranded complex (hybrid) 
which can be visualised by detection of the label. RNA-RNA hybrids are considered to be the 
  Introduction 8 
most stable hybrids, followed by RNA-DNA, and DNA-DNA hybrids being the least stable 
(Morel and Cavalier, 2000).  
There are several options for labels. Besides labelling with radioisotopes (3H, 35S, 32P and 33P) 
as immediate constituents of the nucleotides which are visualised by autoradiography, 
nonradioactive molecules can be coupled to the probes which in turn can be detected by two 
different methods. First, in the direct method the label molecule (fluorescein) is bound to the 
nucleic acid probe and can be detected directly under the fluorescence microscope. Second, 
the indirect procedures require the probe to contain a reporter molecule with antigenic 
properties (biotin, digoxigenin (DIG)). Subsequently, the reporter molecules is visualised by 
an immunologic pathway, i.e. via an antibody either coupled to fluorescein or to an enzyme 
finally activating chromogenic substrates. These signals can be detected by fluorescence or 
brightfield microscopy, respectively. Moreover, unique to the immunological pathway is the 
possibility of extending the immunologic detection system by the use of several antibodies in 
succession to further enhance the ISH signal. This is not possible with a radioactive system. 
The advantages of nonradioactive probes are denoted as safety, stability, rapid results and 
single cell resolution, while generally a higher sensitivity is credited to radioactive probes 
(summarised according to Wilkinson (1998) and Morel and Cavalier (2000)). However, 
Femino et al. (1998) were capable of visualising a single RNA transcript in single cells by 
fluorescence ISH. 
In the present study, the target nucleic acid was Hp mRNA to be detected by the indirect 
method via DIG. 
1.5 Aim of this study 
Hp mRNA expression has recently been validated in homogenates of the bovine mammary 
gland, but the exact cell types responsible for Hp mRNA synthesis have not yet been 
specified. The aim of this study was to advance this finding by allocating Hp gene expression 
within the bovine mammary gland at the cellular level. This was to be addressed by 
investigating immune cells of the blood for the presence of Hp mRNA, since these cells can 
infiltrate the udder. In support of this, milk somatic cells were to undergo the same 
examination since they comprise mainly blood derived immune cells. The main task was to 
localise in situ Hp mRNA within the bovine mammary gland. For this purpose, an 
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experimental infection model was to be applied by inoculating cows intramammarily with 
E. coli or Staph. aureus pathogens. Besides determining sites of Hp mRNA expression in 
general, this also allowed assessing in situ possible differences specific for these two mastitis 
pathogens regarding site and abundance of Hp mRNA within the mammary gland. Finally, 
human blood cells and human mammary gland were to be tested in comparison. 
 
 2 Materials and Methods 
2.1 General laboratory practice 
Particular care was taken to work ribonuclease (RNase) free. Generally, working benches 
were cleaned with 80% ethanol. Before the start of ISH, benches and pipettes were 
additionally wiped with 0.1 M HCl. The inside of the cryostat was cleaned with chloroform. 
Glass and metal ware was baked at 180°C for at least 6 h. Thermostable plastic ware was 
autoclaved at 121°C for 20 min.  
Chemicals, composition of buffers and solutions, instruments and consumables used in this 
study are listed in the appendix. 
2.2 Sample origin and collection 
2.2.1 Dairy cattle 
Animals from three different sources were available for this study depending on the type of 
samples required. 
Firstly, for Hp mRNA detection by polymerase chain reaction (PCR) within cells of blood 
and milk the appropriate samples were taken from nine cows appearing healthy and selected 
at random out of 25 German Holsteins (Deutsche Schwarzbunte) of the dairy herd at the 
research station Frankenforst in Königswinter. This research station belongs to the University 
of Bonn, Germany. 
Secondly, mammary gland tissue for in situ hybridisation was derived from six German 
Holstein dairy cows in the middle of their first or second lactation after experimental 
intramammary infection. The milk of these animals had been tested free of mastitis pathogens 
by weekly bacteriological tests three times pre-trial and, additionally, to have somatic cell 
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counts < 100,000 cells/ml in all three samples. The six animals were split into two groups of 
three each and experimentally infected intracisternally with either E. coli (500 cfu) or Staph. 
aureus (104 cfu). These pathogens contained in 2 ml saline were administered into the front 
right, hind right and hind left quarter at 0 h (T0), 12 h (T12) and 18 h (T18) after the start of 
the trial, respectively. The front left quarter received 2 ml pathogen-free saline at T0. The 
cows were milked at T0, T12 and at 24 h after start of trial (T24) and were finally slaughtered 
at T24. This experiment was conducted by Dr. Holm Zerbe and his staff at the University of 
Veterinary Medicine, Hanover, Germany, who provided the trial animals and pathogens and 
enabled the sampling of the tissues required for this study. The pathogens applied in this trial 
originated from milk of clinical mastitis cases tested positively for exactly one of the two 
desired pathogen types. The isolated bacteria had been grown in pure culture and stored in 
glycerol at -20°C. 
Thirdly, liver samples for control purposes were collected from cows at the abattoir in 
Euskirchen, Germany 
Cows from these three sources are in the following referred to as Frankenforst cows, Hanover 
cows and Euskirchen cows, respectively. 
2.2.1.1 Blood  
For leukocyte preparation, blood from six Frankenforst cows was taken by venipuncture from 
the jugular vein into 50 ml disposable polypropylene tubes preloaded with 10 µl heparin (i.e. 
5000 IU heparin/l blood). Heparin concentration had been optimised in pilot studies to reduce 
adherence of leukocytes for their subsequent harvest: 5000 IU/l produced superior results 
compared to 10,000 or 15,000 IU/l blood. Immediately after sampling the tubes were gently 
inverted to mix the heparin with the blood and then transported in ice water to the laboratory 
for the immediate isolation of leukocytes. 
Serum samples from blood withdrawn from the six Hanover cows at T0, T12, T18 and T24 
were prepared by the cooperating group in Hanover and made available for the current study. 
Samples were stored at -20°C until Hp protein assay. 
2.2.1.2 Milk  
For the preparation of somatic cells, milk was collected from another three Frankenforst cows 
during morning milking. The quarter for sampling was chosen by ease of access to that 
quarter, which was first brushed to remove any lose particles of dirt, skin or hair. Next, the 
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bottom part of the quarter and the entire teat were disinfected with 80% ethanol. After the first 
few squirts were discarded, 200 ml of milk were hand-stripped into an autoclaved glass jar. 
The milk was kept in ice water during transportation to the laboratory and then processed 
immediately for cell preparation. 
Milk samples of all four quarters of the six Hanover cows were taken just prior to slaughter 
(T24) in a similar manner as described above. At T24 the four individual quarters had been 
exposed to the pathogens for a total of 0 h, 6 h, 12 h and 24 h, respectively. Milk was 
skimmed after centrifugation (2000 g, 15 min, 4°C) and stored at -20°C until Hp protein 
analysis. 
2.2.1.3 Mammary gland and liver tissue 
Tissue samples of the mammary gland were taken immediately after slaughter from the 
Hanover cows for in situ hybridisation. The main focus of the evaluation for Hp mRNA was 
on secretory tissue and not teat, cistern and duct system; hence, the samples were excised 
from the gland accordingly. Cubes (approximately 1 cm3) were removed with scalpel, forceps 
and scissors, rinsed in 0.9% NaCl and transferred to a 7 ml sample vial. Cubes of the same 
tissue were either snap frozen in liquid nitrogen directly, or first embedded in Tissue Tek® 
OCT™ Compound within the vial and then snap frozen. The samples were transported on dry 
ice to the laboratory and stored at -80°C. Liver samples of these cows were taken likewise. 
In addition, liver tissue samples were sourced from Euskirchen cows in a similar manner. 
Total RNA was extracted from these samples and served as PCR control.  
2.2.2 Humans 
Four human volunteers (three females, one male) aged between 21 and 34 years and 
appearing healthy were available for blood collection. 
2.2.2.1 Blood  
For leukocytes preparation, blood of the four candidates was taken from a vein in the inner 
elbow region into four 12 ml syringes preloaded with 60 µl of a heparin solution. This heparin 
solution was prepared by diluting the purchased heparin 1:25 in sterile saline. This extra step 
yielded improved results in cell preparation from human whole blood samples compared to 
using undiluted heparin directly. Final heparin concentration was 5000 IU/l blood. 
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Immediately after sampling, the tubes were gently inverted to mix the heparin with the blood, 
and then transported in ice water to the laboratory for immediate cell isolation.  
2.2.2.2 Liver tissue 
No liver tissue samples were processed for RNA extraction. Instead, human liver Poly (A)+ 
RNA was kindly donated by Dr. Jens Gruber, RWTH Aachen University, Germany.  
2.2.2.3 Mammary gland 
Total RNA of human mammary gland was purchased from BD Biosciences, Heidelberg, 
Germany. Hence, no tissue samples were required for RNA extraction. 
2.3 Principal molecular biology methods used 
2.3.1 RNA preparation 
2.3.1.1 Total RNA extraction 
Total RNA was prepared from the isolated cells or tissue samples according to the method by 
Chomczynski and Sacchi (1987) with some modifications (Chomczynski and Mackey, 1995). 
All solutions used were prechilled to 4°C. Tissue samples (approximately 200 to 400 mg) 
were homogenised in a protein-denaturing GTC-working solution (1 ml/100 mg tissue) with a 
dispersing tool (Ultra Turrax), whereas blood or milk cell pellets were dissolved in GTC-
working solution by simply pipetting up and down. After addition of water saturated phenol 
(1 vol/vol GTC-solution) and 1-bromine-3-chlorine propane (0.2 vol/vol GTC-solution) and 
subsequent thorough mixing, the solution obtained had to be of milky appearance. If this was 
not the case, further 1-bromine-3-chlorine propane was added up to 0.8 vol/vol GTC-solution 
until the required colour was achieved. This solution was blended with 2 M Na-acetate 
(0.2 vol/vol GTC solution), mixed thoroughly for 1 min, incubated on ice for 15 min and 
centrifuged (1.5 ml tube: 10,000 g, 4°C for 20 min; 15 ml tube: 5000 g, 4°C for 30 min). The 
RNA, present in the aqueous supernatant, was precipitated by an equal volume of isopropanol 
during 5 min at -80°C and subsequent centrifugation as mentioned above. After two washing 
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steps with 1 ml 70% ethanol, including 15 min incubation at room temperature during the 
second wash, and centrifugation at 10,000 g, 4°C for 5 min, the RNA-pellet was dissolved in 
DEPC-treated water and stored at -80°C. 
For liver tissue an additional protein denaturing and RNA precipitation step was included 
following the first precipitation by isopropanol to further remove connective tissue 
components and, thus, improve RNA purity. This step, though part of the original protocol, 
had previously been tested to be optional when extracting RNA from blood and milk somatic 
cells; in fact, its omission led to a higher RNA yield from these cells. The step comprised: 
GTC-working solution (100 µl/100 mg tissue) and 2 M Na-acetate (0.1 vol/vol GTC-solution) 
were added in which the pellet was to be dissolved during 20 min incubation at room 
temperature. Again the RNA was precipitated in an equal volume of isopropanol as described 
above.  
2.3.1.2 Quantification of RNA by optical density 
The total RNA dissolved in the DEPC-treated water was quantified by measuring the 
absorption of nucleic acids at 260 nm in a spectrophotometer. One unit of optical density at 
260 nm (OD260) corresponds to an RNA quantity of 40 µg/ml. This leads to the following 
equation to estimate the RNA concentration: 
RNA (µg/ml) = OD260 * 40 µg/ml * dilution factor. 
For this work the solution was diluted 1:100. 
As a measure of protein contamination the ratio of absorbance at 260 nm (wave length of high 
absorption by nucleic acids) to the absorbance of 280 nm (wave length of high absorption by 
proteins) was established. Only samples with a ratio > 1.6 were used for further analyses. 
2.3.1.3 DNase digest 
The RNA samples underwent a digest of DNA to prevent false positive results produced by 
any residual genomic DNA in the subsequent DNA amplification reactions. Depending on the 
amount and the concentration of the original RNA as well as the desired amount and 
concentration of the RNA required for the subsequent reverse transcription, the 
desoxyribonuclease (DNase) digest was carried out in a total reaction volume of 15 or 25 µl. 
For each assay, a master mix was prepared with DNase I (0.5 µl/sample) and the appropriate 
volume of 10x reaction buffer (1.5 or 2.5 µl). This mix was aliquoted to the 1.5 ml tubes 
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prefilled with the amount of RNA solution to be subjected to the digest. The final volume was 
adjusted with DEPC-treated water. The digest was performed during 15 min incubation at 
37°C and the reaction stopped at 75°C for 5 min. The RNA concentration of the solutions 
obtained was quantified again by photometry as described above. If this RNA concentration 
was > 0.5 µg/µl, an aliquot was diluted to a working concentration of 0.3 µg/µl. 
2.3.1.4 Quality control of the RNA extracted 
The integrity of the RNA extracted was verified by denaturing gel electrophoresis. For this 
purpose 3 µg of total RNA were mixed with 3 µl 5x RNA loading buffer and an appropriate 
volume of DEPC-treated water to achieve a total volume of 15 µl. This mixture was denatured 
at 65°C for 10 min. Immediately afterwards the samples were cooled on ice to preserve the 
denatured structure of the RNA. The gel contained 1.2% agarose which was initially 
dissolved in ultra pure water by boiling. After cooling down to 60°C, 10x MOPS buffer and 
deionised formaldehyde were added resulting in a final concentration of 1x MOPS and 
12.5 M formaldehyde. The gel was immersed in 1x MOPS buffer and run at 3.5 V/cm for 
1.5 h after pipetting the samples into the gel slots. The RNA bands were visualised under UV 
light (FluorImager SI). 
A high quality of extracted total RNA is indicated by the presence of two distinct bands 
representing the ribosomal RNA (rRNA) subunits 28S and 18S after agarose gel 
electrophoresis. Ideally, the intensity of the 28S band should be twice the intensity of the 18S 
band. In contrast, these bands appear smeared or are even completely lacking when the RNA 
is partially degraded (Ivell, 1998). In the first place, these bands are a measure of the quality 
of rRNA only, but they are also considered to reflect the quality of total RNA including 
mRNA that was of interest for this study. 
2.3.2 Reverse transcription (RT) 
The RT serves to synthesise a first strand complementary DNA (cDNA) from an RNA 
template (Gerard and Grandgenett, 1975). The enzyme reverse transcriptase catalyses this 
reaction in the presence of primers. For this work the method of random priming with 
randomised hexanucleotide sequences was chosen allowing complete transcription of total 
RNA into cDNA (Veres et al., 1987). 
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The protocol had previously been validated for the transcription of 1 µg total RNA in a 
reaction volume of 20 µl. The RNA was denatured at 65°C for 5 min and immediately cooled 
down to 4°C to preserve its linearised structure. The random hexamer primers annealed to this 
denatured RNA during 10 min at 27°C, followed by the reverse transcriptase activity for 1 h 
at 42°C. The reaction was stopped at 99°C for 1 min, and the preparation cooled to 4°C. See 
Table 2.1 for reagents used and their final amounts. 
 
Tab. 2.1: RT reagents used and their final amount in 20 µl reaction volume. 
RT reagents Final amount in 20 µl 
Ultra-pure H2O Ad 20 µl 
Random hexamer 50 pmol 
5x Reaction buffer 1x 
dNTP  
(dATP, dCTP, dGTP and dTTP) 
10 nmol of each  
Ribonuclease inhibitor 20 U 
Reverse transcriptase 200 U 
 
 
2.3.3 Polymerase chain reaction (PCR) 
The PCR is a technique to generate a large number of copies of DNA segments. Similar to the 
RT, the key reagents are the primers and an enzyme, the DNA polymerase. However, contrary 
to the RT, the PCR primers for this study were chosen to act not at random, but specifically 
for a DNA region and, hence, for the gene of interest. The principle of the PCR is the 20 to 
40-fold cyclic repetition of three steps: firstly, denaturing of double stranded DNA or a DNA-
RNA complex to single strands, secondly, annealing of the primers and, thirdly, extending of 
the primer sequence to a complementary copy of the whole template (Mullis and Faloona, 
1987).  
2.3.3.1 Selection of primers for the genes of interest 
The main gene of interest was Hp. Species specific primers were applied to samples of bovine 
and human origin, since the use of bovine Hp primers did not yield any PCR products from 
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human liver RNA. Also two different primer pairs (bHp1 and bHp2) for the bovine Hp gene 
were applied yielding PCR products of different lengths. The longer PCR fragment (bHp2) 
became relevant only during establishing the in situ hybridisation protocol and was not used 
in standard PCR investigations which were carried out with bHp1 primers. For convenience, 
in the following bHp1 and bHp2 may denote not only the respective PCR fragments but also 
the corresponding primer pairs. 
Besides the Hp gene, primers for bovine β-actin as internal control gene were selected and 
applied to samples of both species. Specificity of the PCR products for both species was 
established by sequencing (Value Read, MWG Biotech AG, Ebersberg, Germany).  
Table 2.2 provides details on NIH gene bank accession number, the literature source of the 
primer sequences, the PCR fragment size, and the primer sequences used. The cDNA 
sequences of bHp and hHp currently known are given in the appendix. 
 
Tab. 2.2: NIH gene bank accession number, literature source of PCR primer sequences, 
the PCR fragment size and the forward (F) and reverse (R) primer sequences 
for the genes bHp, hHp, and β-actin. 
PCR 
frag-
ment 
NIH gene 
bank 
accession 
Literature 
source 
Frag-
ment 
size 
(bp) 
Primer sequences 
F = 5'-GTCTCCCAGCATAACCTCATCTC-3' 
bHp1 AJ271156 Hiss et al. (2004) 174 R = 5'-AACCACCTTCTCCACCTCTACAA-3' 
F = 5'-CCAAAGGCAGCTTTCCTTGG-3' 
bHp2 AJ271156 Lavery et al. (2004) 302 R = 5'-GGAAGGTAGGCAGATGGGCAT-3' 
F = 5'-CCTGAATGTGAAGCAGTATGT-3' 
hHp NM_005143 Chen et al. (1998) 338 R = 5'-TTCTGTTTGAGTTTGATGAGC-3' 
F = 5'-CGTGGGCCGCCCTAGGCACCA-3' 
β-actin AY141970 
Fitzpatrick 
et al. 
(2002) 
226 
R = 5'-GGGGGCCTCGGTCAGCAGCAC-3' 
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2.3.3.2 Implementation of the PCR 
A protocol optimised in the laboratory beforehand was used to implement the PCR. A Master 
Mix was prepared containing 10x Taq buffer with (NH4)2SO4, MgCl2, dNTPs, Taq DNA 
polymerase and the forward and reverse primers (Table 2.3). This mixture (47 µl) was added 
to 3 µl of cDNA to achieve a total PCR reaction volume of 50 µl. The temperature and time 
conditions for the complete PCR are shown in Table 2.4. 
 
Tab. 2.3: PCR reagents used and their final concentration in 50 µl. 
PCR reagents Final concentration in 50 µl 
Ultra-pure H2O Ad 50 µl 
10x Taq buffer with (NH4)2SO4 1x 
MgCl2 2 mM 
dNTPs 
(dATP, dCTP, dGTP and dTTP) 
100 µM each 
Primer forward 0.4 µM 
Primer reverse 0.4 µM 
Taq DNA polymerase 1.0 U 
 
Tab. 2.4: Temperature and time conditions of the PCR steps. 
Fragment  
bHp1 bHp2 hHp β-actin 
Hot start 72°C 72°C 72°C 72°C 
Denaturation 95°C 1 min 95°C 1 min 95°C 1 min 95°C 1 min 
Denaturation 94°C 40 sec 94°C 40 sec 94°C 40 sec 94°C 30 sec 
Primer annealing 55°C 20 sec 60°C 30 sec 55°C 30 sec 55°C 30 sec 
C
yc
le
 
Extension 72°C 20 sec 72°C 40 sec 72°C 40 sec 72°C 1 min 
Number of cycles 37 34 34 30 
Final extension 72°C 5 min 72°C 5 min 72°C 5 min 72°C 5 min 
Cooling 4°C ∞ 4°C ∞ 4°C ∞ 4°C ∞ 
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2.3.3.3 Visualisation of PCR products by DNA gel electrophoresis 
A successful PCR is characterised by the formation of numerous PCR products of the correct 
fragment length determined by the PCR primers. These PCR products were checked by DNA 
gel electrophoresis. PCR products (10 µl) with 5x DNA loading buffer were separated in a 2% 
agarose gel containing 0.3 µg ethidium bromide/ml in 1x TBE buffer at 4 V/cm for 60 to 75 
min. After the electrophoresis the DNA bands were visualised by UV-laser scanning system 
(FluorImager SI) and analyzed by image analysis software (Peak Finder, ImageQuaNT™). 
The fragment size was assessed by comparison to a DNA molecular weight marker (200 ng, 
ΦX174 DNA/BsuRI (HaeIII)). 
2.3.3.4 Reamplification 
Negative results from the standard PCR method were to be confirmed by PCR 
reamplification. For this purpose, 1 µl of first course PCR products plus 2 µl of ultra-pure 
H2O, instead of 3 µl cDNA, were reamplified under the PCR conditions mentioned above. 
Reamplification of PCR products is a tool widely used as part of the differential display 
method identifying and isolating genes differentially expressed (Wang et al., 1998). 
2.3.4 Controls for RT-PCR 
Liver RNA was used as positive RT-PCR control. One µg total RNA from bovine liver and 
0.075 µg Poly (A)+ mRNA from human liver were subjected to RT-PCR, taking into account 
that total RNA comprises approximately 5 to 10% of Poly (A)+ mRNA (Alberts et al., 1997). 
Water was used as negative RT-PCR control. In order to control any residual genomic DNA, 
each RNA sample was also subjected to RT-PCR without the addition of reverse 
transcriptase. β-actin served as a suitable internal control gene to check the integrity of the 
cDNA synthesis and PCR. For β-actin primers and PCR condition refer to Tables 2.2 and 2.4.  
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2.4 Detection of Hp mRNA in bovine blood and milk 
somatic cells as well as in human blood cells and 
mammary gland by RT-PCR 
Cells were to be extracted from the collected blood and milk for further investigation of Hp 
mRNA within these cells. Before processing the required buffers (1x PBS, 2x PBS) and ultra-
pure H2O were chilled to 4°C unless stated otherwise. It was important that the PBS was free 
of the divalent cations Mg2+and Ca2+ to prevent coagulation of the blood cells. During 
processing the samples were kept in ice water. The centrifugation was carried out in a swing-
out rotor, without brakes and at 4°C unless stated otherwise.  
2.4.1 Blood processing for cell separation 
2.4.1.1 Isolation of leukocytes 
The isolation of leukocytes was based on their lower density compared to erythrocytes. After 
centrifugation of heparinised whole blood the leukocytes aggregate at the plasma-erythrocyte 
interphase and form the so called "buffy coat". Lysis of undesirable erythrocytes was carried 
out following the protocol of Krüger (2001). 
Upon arrival at the laboratory 48 ml of whole blood of each individual were transferred in 
equal portions to four 15 ml tubes and centrifuged for 20 min at 1100 g (bovine blood) and 
700 g (human blood). After discarding the plasma, the buffy coats of the four tubes were 
collected with a sterile Pasteur pipette and combined in one 15 ml tube. Contaminating 
erythrocytes were removed by hypotonic lysis: 5 ml ultra-pure H2O were added and mixed by 
inversion for 20 sec; thereafter isotonicity was restored with 5 ml 2x PBS, followed by 
centrifugation at 100 g for 8 min. For complete elimination of erythrocytes the lysis was 
repeated. It appeared helpful to resuspend the cell pellet in 1 ml 1x PBS before the second 
lysis to allow an optimal mixing of the water with all cells during the short incubation time. 
After the lyses the pellet was again resuspended and the cells washed in 10 ml 1x PBS; of this 
a 100 µl subsample was removed for cell differentiation by a smear and cell count in a 
counting chamber (see below). Finally, the cell suspension was centrifuged as above, the 
supernatant discarded and the pellet stored at -80°C until further processing. 
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2.4.1.2 Isolation of mononuclear and polymorphonuclear cells  
The isolation of mononuclear (lymphocytes and monocytes) and polymorphonuclear 
leukocytes (neutrophilic, basophilic and eosinophilic granulocytes) is based on the principle 
of density gradient centrifugation. Blood is applied to a separation medium which after 
centrifugation and due to different sedimentation rates accumulates the mononuclear cells at 
the plasma-medium interphase, and the polymorphonuclear cells and erythrocytes as a pellet 
below the medium.  
This procedure was applied only to bovine blood and according to the protocol of Krüger 
(2001) with some modifications. Fifty ml of heparinised blood were diluted 1:2 with 1x PBS. 
Ninety ml of this mixture were split into three equal portions of 30 ml each and the remaining 
10 ml discarded. Each portion was then carefully layered on 15 ml Histopaque®-1077 in a 
50 ml vial and centrifuged (1100 g, 30 min, room temperature). Both PBS and Histopaque®-
1077 were employed at room temperature. 
For the harvest of mononuclear cells (MNC), the upper plasma layer was aspirated to within 
0.5 cm of the opaque interphase and discarded. The interphases, containing the MNC, of the 
three tubes were then transferred by a Pasteur pipette to a new 50 ml tube and pooled. These 
cells were washed with 25 ml 1x PBS and centrifuged at 430 g for 10 min. If an unexpected 
erythrocyte contamination was observed in the pellet obtained, a lysis was introduced as 
described above with 20 ml ultra-pure H2O, 20 sec incubation time, 20 ml 2x PBS and 
centrifugation at 430 g for 10 min. This pellet was washed again with 10 ml PBS. After a 
100 µl subsample had been taken for a smear and cell count, the suspension was centrifuged 
at 250 g for 10 min. The supernatant was discarded and the pellet stored at -80oC.  
Polymorphonuclear cells (PNC) were prepared as follows: In the original tube after the 
removal of the mononuclear cells, the Histopaque®-1077 phase was aspirated to within 0.5 cm 
of the red pellet and discarded. The contaminating erythrocytes in the pellet were lysed 
hypotonically similarly to above by 20 ml ultra-pure H2O, 20 sec incubation period, 20 ml 
2x PBS, and the suspension centrifuged at 100 g for 8 min. After resuspension of the pellet in 
1 ml 1x PBS, the solution was transferred to a 15 ml tube and the lysis repeated with a volume 
of 5 ml ultra-pure H2O and 5 ml 2x PBS. Finally, the pellets of the three repeats were pooled, 
washed in 10 ml 1x PBS´. After a 100 µl subsample had been taken, the suspension was 
centrifuged at 100 g for 8 min. The supernatant was discarded and the pellet stored at -80°C. 
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2.4.1.3 Leukocyte differentiation by blood smears 
Firstly, from all whole blood samples a white blood cell differential was established to check 
for any irregularities in each individual. Secondly, a differential was required of the extracted 
cells to determine their composition and, in particular, purity of the isolated cell fractions. 
For this purpose one drop of whole blood or one drop of purified cells diluted 1:2 in bovine 
plasma beforehand was spread onto a SuperFrost® Plus microscope slide by a glass cover slip. 
Mixing the isolated cells with plasma enhanced the attachment of these cells to the slide. The 
cell-free plasma used herein was prepared from the blood of one trial animal and kept at 
-20°C. After drying overnight at 37°C the slides were stained according to the method of 
Pappenheim (Romeis, 1989) and 100 cells were differentiated microscopically with 660x 
magnification. 
2.4.1.4 Cell count and cell viability 
An estimate of the number of cells isolated and their viability after the purification process 
was obtained by the use of a counting chamber and Trypan Blue staining, respectively. The 
Trypan Blue penetrates into non-vital cells only, whereas vital cells exclude the stain. The 
presence of contaminating erythrocytes was also assessed in the counting chamber and 
differentiated from the leukocytes by their smaller size. 
For this purpose, 25 µl of the 100 µl subsample taken before (see above) were mixed with 
25 µl of Trypan Blue solution (Trypan Blue stain diluted 1:4 in ultra-pure H2O), applied to the 
Neubauer counting chamber according to the manufacturer's protocol and the cells evaluated 
at 260x enlargement within 30 min thereafter. Cells were counted in eight small squares of the 
counting chamber instead of the 64 recommended by the manufacturer, since only an estimate 
of the isolated cells was needed.  
2.4.2 Milk processing for cell separation 
For cell preparation from cow's milk the protocol by Boutinaud et al. (2002) preparing 
somatic cells from goat's milk was adapted. Somatic cells were isolated from 200 ml milk. 
The milk was diluted 1:2 with 1x PBS and centrifuged in two 200 ml beakers at 1000 g for 
15 min. The fat layer was removed with a spatula and a Pasteur pipette, and the skimmed milk 
was discarded. After each cell pellet had been resuspended in 1 ml 1x PBS the two 
suspensions were combined in one 50 ml tube, washed with 48 ml 1x PBS and centrifuged at 
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200 g for 10 min. Again, the pellet was dissolved in 1 ml 1x PBS and subsequently 
transferred to a 1.5 ml tube. After a further centrifugation step the pellet was frozen at -80°C. 
An attempt was made to analyze the extracted cells for type or count similarly to blood cells. 
However, fat globules within the milk interfered with the accuracy of differentiating cells in a 
smear or counting cells in the counting chamber, both leading to unsatisfying results. Hence, 
these analyses were abandoned.  
2.4.3 RT-PCR with RNA from separated cells 
The cells separated from blood and milk were processed for total RNA extraction and RT-
PCR with bHp1 and hHp primers for cows and humans, respectively, as described above. 
Since standard RT-PCR for the hHp gene revealed no positive results with RNA from human 
blood cells, these PCR products underwent reamplification.  
2.4.4 RT-PCR with human mammary gland RNA 
Human mammary gland total RNA, as described above in "Sample origin", had been 
purchased and, hence, required no extraction from tissue sample. However, prior to RT-PCR, 
this RNA was subjected to a DNase digest to ensure removal of possible contaminations with 
genomic DNA.  
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2.5 Cellular localisation of Hp mRNA in the mammary 
gland by in situ hybridisation (ISH) 
Hp mRNA was to be localised in tissue sections of the bovine mammary gland by ISH. As 
mentioned in the introduction a non-radioactive probe with the reporter molecule DIG to be 
detected by the indirect method was applied for this purpose. It involved the following six 
steps: 
1. Generation of a nucleic acid probe 
2. Tissue preparation including sectioning and fixation 
3. Pretreatment to increase accessibility of target RNA 
4. Hybridisation of probe to the target RNA 
5. Posthybridisation washes to remove unbound or unspecifically bound probe 
6. Immunological detection of hybrids and visualisation. 
2.5.1 Generation of RNA probe 
The RNA probes used for ISH were generated and simultaneously labelled by in vitro 
transcription from a DNA template (Morel and Cavalier, 2000), and the purified product 
subsequently quantified in a dot blot. Two homologous probes and one heterologous (human) 
probe were tested on bovine tissue. They are referred to as bHp1, bHp2 and hHp probes in the 
following corresponding to the PCR primers employed in the template amplification. Hence, 
the probe lengths were 174, 302 and 338 nt, respectively. These three probes were tested in 
the following chronological order: bHp1, hHp and bHp2. An ISH protocol could be 
established with bHp1 probe for liver with moderate staining, whereas no staining was 
achieved in the mammary gland using the same conditions. Similar unsatisfying results were 
obtained with the longer, but heterologous hHp probe in both tissues. Finally, best results 
were achieved with the bHp2 probe, the corresponding primer sequence of which was only 
published while establishing this ISH protocol (Lavery et al., 2004).  
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2.5.1.1 DNA template synthesis and purification 
The DNA template required for the probe synthesis consisted of purified RT-PCR products 
from bovine or human liver RNA. Two different templates were required allowing the 
separate synthesis of antisense (as) and sense (s) probes. This was achieved by extending one 
of the two Hp PCR primers at its 5'-end by the sequence of the T7-RNA-Polymerase 
promotor plus some "filling" sequences to allow optimal attachment of the enzyme. This 
filling sequence had been successfully tested by Hakemann (2002). One primer sequence is 
schematically shown in Figure 2.1.  
The PCR with the Hp (forward) and T7+Hp (reverse) primers led to the template for the 
antisense probe and with T7+Hp (forward) and Hp (reverse) primers to the template for the 
sense probe. The sequence of all three standard Hp primer pairs and the appropriate 
conditions for PCR amplification can be found above (Tables 2.2 and 2.4). The PCR products 
were assessed on a 2% agarose gel for quality and quantity, using image analysis software 
(Volume Report, ImageQuaNT™) for quantification. 
The subsequent purification of the obtained PCR products provided optimal conditions for the 
transcription reaction by removing contaminations of primers, buffers and enzymes, and was 
carried out using the QIAquick PCR-purification kit according to the manufacturer's protocol.  
 
5'-CCAAGCTTCTAATACGACTCACTATAGGGAGACCAAAGGCAGCTTTCCTTGG-3'
T7 promoter sequence bHp2 forward primer sequence filling filling 
Fig. 2.1: bHp2 forward primer extended by the T7 promoter sequence and filling 
sequences. This primer together with the standard bHp2 reverse primer was 
used to generate a DNA template required for ISH sense probe synthesis.  
 
2.5.1.2 Probe synthesis by in vitro transcription 
The in vitro transcription of the DNA template to single-stranded RNA probe in the presence 
of Dig labelled UTPs by the T7 RNA polymerase was carried out according to the 
manufacturer's instructions of the DIG RNA labelling kit (Roche) with some modifications 
(personal communication with PD Dr. Stephan Baader, Institute of Anatomy, Anatomy and 
Cell Biology Group, University of Bonn, Germany) as described below. The Dig labelled 
UTPs as part of the NTP labelling mixture leads to a probe with a Dig labelled nucleotide 
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incorporated every 20th to 25th nucleotide. 200 ng DNA template were added to DEPC-treated 
H2O to a final volume of 13 µl and left to stay at room temperature for the Master Mix to be 
added. This Master Mix was prepared at room temperature with 
• 2 µl 10x Dig NTP labelling mixture 
• 2 µl 10x transcription buffer 
• 1 µl RNase inhibitor 
• 2 µl T7 RNA polymerase 
and added to the template. It was important that the transcription buffer was brought to room 
temperature before mixing to avoid DNA precipitation by the spermidin contained in the 
buffer. Consequently, the complete Master Mix was prepared and left to stay at room 
temperature. However, care was taken to work as time efficiently as possible. After gentle 
mixing and brief centrifugation the preparation was incubated at 37°C for 2 h. After this 
incubation, a second Master Mix containing 
• 1 µl 10x transcription buffer 
• 1 µl 10x Dig NTP labelling mixture 
• 7 µl DEPC-treated H2O 
• 1 µl T7 RNA polymerase 
was added and incubated at 37°C for one additional hour to increase the yield of the reaction. 
The reaction was stopped by adding 3 µl 0.2 M EDTA (pH 8.0). In the case of several 
reactions per probe the content of tubes containing the same probe was pooled at this stage.  
Next, the yielded probe was purified to remove undesirable components of the transcription 
reaction, particularly salts. First, the RNA was precipitated in 0.1 vol 4 M LiCl and 2.5 vol 
100% ice cold ethanol at -20°C for a minimum of 1 h, preferably overnight. After 
centrifugation (13,000 g, 15 min, 4°C) the pellet was washed in 200 µl 70% ice cold ethanol 
and centrifuged again for 10 min. The pellet obtained was air dried, dissolved in 100 µl 
DEPC-treated H2O and stored at -20°C. 
2.5.1.3 Probe quantification by dot blot 
As the final step of probe generation, the yield of the probe was quantified by a direct 
detection method (dot blot). A series of dilutions of Dig labelled RNA probe was applied to a 
positively charged nylon membrane. In parallel, the nylon membrane was loaded with a 
dilution series of Dig labelled RNA of known concentration ranging from 10 ng/µl to 30 pg/µl 
serving as standard. The nylon membrane was subjected to immunological detection and the 
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probe concentration determined by eye assessment of the staining intensities of the probe 
compared to the standard. NBT and BCIP were used in combination as substrate. BCIP is 
oxidised to indigo while NBT in a simultaneous coupled reaction is reduced to diformazan, 
both of which lead to the formation of blue insoluble precipitates. The colour of the 
precipitates might be recognised not only as blue but also as brownish or purplish depending 
on the type of membrane used (Roche, 2002). 
First, the Dig labelled control RNA stock (100 ng/µl) provided with the above mentioned kit 
was diluted 1:10 in RNA dilution buffer to a working concentration of 10 ng/µl. Next, 
dilution series of this working solution as well as of the undiluted probe were created: 1:3.3, 
1:10, 1:33, 1:100, and 1:330, 1 µl each of which was loaded onto the nylon membrane placed 
in a plastic petri dish. Next the membrane underwent the following immunological detection: 
• UV light to fix the RNA to the membrane, 5 min 
• 10 ml MA buffer to equilibrate, 1 min 
• 9 ml MA buffer + 1 ml 10% Blocking Reagent, 30 min, shaking (100 rpm, Shaker 
3005) 
• brief wash with MA buffer 
• 15 ml MA buffer + 3 µl Anti-Dig-AP (Fab fragments, Roche; 1:5000 dilution), 
30 min, shaking (100 rpm) 
• substrate buffer 1 to equilibrate, 2 min 
• 10 ml substrate buffer + 45 µl NBT + 35 µl BCIP, 10 – 30 min, incubate protected 
from light until suitable staining had developed 
• TE buffer to stop the reaction, 10 min 
• air dry membrane. 
Finally, the probe concentration was determined by eye assessment. A stock subsample was 
diluted in DEPC-treated H2O to a working concentration of 10 ng/µl, aliquoted and stored at 
-20°C. Labelled probes are stable for 1 year when stored at -20°C according to Roche.  
It was important to ensure that the nylon membrane never dried out during processing until 
the staining was completed. 
2.5.2 Preparation and fixation of sections  
The preparation of cryostat sections comprises three steps: warming of the tissue sample, 
cutting the sections and fixing the sections.  
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First, the vials containing the tissue samples stored at -80°C were placed into the 
cryomicrotome (Leica) for a minimum of 3 h to allow the sample to warm to the chamber 
temperature in the cryostat (-21°C).  
Second, sections of a thickness of 12 µm (liver, mammary gland) were prepared at a specimen 
temperature of -18°C and a cutting angle of 2-3°, and were deposited on room temperature 
warm SuperFrost® Plus microscope slides. These slides were immediately placed on the 
quick freeze shelf (-45°C) for the section to refreeze and then kept in a precooled Hellendahl 
glass jar within the cryomicrotome until fixation. The temperatures mentioned for 
cryochamber and specimen had experimentally been optimised for liver and mammary gland 
tissue. An increasing section thickness to 18 µm for mammary gland tissue was also tested 
leaving some cells not cut but intact. Hence, their RNA was retained within the cell until 
permeabilisation and, consequently, might produce better staining results. However, this 
could not be confirmed and, thus, the idea was abandoned. In addition, deposition of the 
sections onto slides having room temperature rather than being precooled to cryochamber 
temperature considerably improved adherence, particularly with mammary gland tissue.  
Third, the sections were fixed in 4% paraformaldehyde (PFA) at room temperature. The aim 
of the fixation process is to inhibit cellular metabolism, to deactivate lytic enzymes and 
endogenous RNases, but also to conserve cellular morphology and nucleic acid integrity. PFA 
achieves this by cross-linking proteins and nucleic acids (summarised according to Morel and 
Cavalier (2000)). Three fixation times were tested: 5, 15 or 30 min. Considering that PFA 
penetrates tissue at a rate of 4 mm/h (Romeis, 1989), fixing 12 µm sections for 5 min would 
be sufficient. However, initial trials with 5 min fixation yielded no positive staining results, 
possibly caused by too short a fixation time. Hence, the fixation period was extended to 
15 min and even 30 min as suggested by Lavery et al. (2004) of which the former turned out 
to be satisfying for the purposes of the present study. Fixation was followed by two washing 
steps in 1x PBS for 5 min each.  
Similarly as for the dot blot, once the sections were immersed in the fixation solution it was 
important to ensure that the sections never dried out during any subsequent steps until the 
staining was completed.  
2.5.3 Pretreatment of sections 
The main aim of the pretreatments is to make the target nucleic acid accessible to a probe. 
This may include modifying or destroying membrane and histone proteins, improving 
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signal/background ratio as well as denaturing the target nucleic acid and the probe (Morel and 
Cavalier, 2000). This chapter describes a selection of single steps which are currently reported 
in the literature to achieve this aim and which were also tested separately or in combination 
for this work. The selection was based on the necessity of the steps determined by factors 
such as fixation method or tissue type.  
One key issue turned out to be the deproteinisation step which seems to be a common 
application to paraffin embedded sections (Molenaar et al., 1992; Mayer et al., 2002; Sayed-
Ahmed et al., 2003), but on which the literature reports are highly varying for frozen tissues. 
While some researchers (Knabel et al., 1998; Sinowatz et al., 2000) are applying a 
combination of Proteinase K and HCl, others work successfully by omitting this step 
completely (Jung et al., 1994; Lavery et al., 2004). Hence, some effort was spent to find the 
optimal treatment of liver and mammary gland tissue which turned out to be the entire 
exclusion of the deproteinisation step. 
Similarly, an attempt was made to determine a treatment of the sections just prior to the 
hybridisation that provides optimal conditions for a successful hybridisation afterwards 
(prehybridisation step). Three options were compared: first, equilibration with 2x SSC only; 
second, equilibration with 2x SSC followed by a mixture of equal volumes of 2x SSC and 
hybridisation buffer (without probe); third, a dehydrating alcohol series. Since the latter two 
options did not reveal any additional benefit over the former, option one was preferred 
because it involved the least work, time and chemicals.  
The other measures applied are briefly summarised as follows: acetylation of sections was 
always carried out, whereas the post-fixation alcohol series was optionally tested and the 
quenching of endogenous peroxidase applied only when required by the chosen hybrid 
revelation system. The paragraphs below describe in more detail the implementation of the 
different pretreatment steps, a selection of which was assessed each round. It is refrained from 
mentioning all combinations assessed as this presentation would be too comprehensive. The 
steps are listed in chronological order as applied in this study, however other orders are 
possible (Morel and Cavalier, 2000; Plenz et al., 2003). They were carried out in Hellendahl 
glass jars at room temperature unless noted otherwise. 
2.5.3.1 Alcohol series 
After the fixation a graded alcohol series can be incorporated into the protocol (Jung et al., 
1994). Ethanol not only has fixating properties, but also extracts lipids from tissue (Romeis, 
  Materials and Methods 30 
1989). This latter function might be important in mammary gland tissue with epithelial cells 
containing fat vesicles. The sections underwent an ascending alcohol series (50%, 70%, 90% 
and 100% ethanol (denatured), freshly diluted in DEPC-treated H2O, 5 min each), followed 
by a descending alcohol series (90%, 70%, 50% ethanol, re-using the solutions from the 
ascending series, 5 min each) and a final washing step in 1x PBS for 5 min. Inclusion of these 
two alcohol series was compared to the omission of both. 
2.5.3.2 Inactivation of endogenous peroxidase 
This step was included only when applying the Tyramide Signal Amplification (TSA) system 
(see below "revelation of hybrid"). It required the inactivation of endogenous peroxidase since 
one of the antibodies used for the immunological detection was coupled to horseradish 
peroxidase (POD). This was assured by incubating the sections in 0.3% H2O2 (1:100 dilution 
of 30% H2O2 in 1x PBS) for 15 min and washing twice in 1x PBS for 5 min. 
2.5.3.3 Deproteinisation 
As suggested by the literature mentioned above, two deproteinisation treatments 
(enzymatically with Proteinase K and chemically with HCl) were tested in combination 
compared to the entire exclusion of their application. Proteinase K is considered to be a 
selective protease for proteins associated with nucleic acids. After equilibration in 1x PBS for 
5 min, different concentrations (1, 10 and 20 µg/ml 1x PBS) of Proteinase K as well as 
different incubation periods (10 and 30 min) were evaluated in a 2x3 Latin square design. The 
selection of PBS as dissolvent and treatment at room temperature, in contrast to 37°C often 
seen in the literature (Molenaar et al., 1992; Knabel et al., 1998), was suggested by PD Dr. 
Stephan Baader because of ease of handling (personal communication). Alternatively to PBS, 
effects of dissolving Proteinase K in 0.2 M Tris, 2 mM CaCl2 were also tested (Molenaar et 
al., 1992; Morel and Cavalier, 2000). No differences were observed, hence, for subsequent 
Proteinase K treatment the ready-to-use buffer 1x PBS was used. The Proteinase K incubation 
was succeeded by two washes in 1x PBS for 5 min. Subsequently, sections were subjected to 
HCl at a concentration of 0.2 M for 10 min, conditions commonly reported in the literature for 
this treatment (Molenaar et al., 1992; Knabel et al., 1998; Morel and Cavalier, 2000) 
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2.5.3.4 Acetylation 
The acetylation reaction is effective in reducing background by transforming the reactive 
amine group (NH3+) of proteins into a substituted amine group (-NH-CO-CH3, neutral) by 
reacting the sections with acetic anhydride (CH3-CO-CH3) in a triethanolamine buffer. For 
this purpose a 0.25% acetic anhydride solution in 0.1 M TEA buffer was prepared only just 
prior to usage because of the instability of acetic anhydride. The sections were incubated in 
this solution for 10 min. 
2.5.3.5 Prehybridisation 
Three options were compared as prehybridisation treatment: 
Option 1: Sections were equilibrated in 2x SSC for 10 min. 
Option 2: Initially, the sections were equilibrated in 2x SSC for 10 min and then pre-
hybridised with 90 µl of a mixture of equal volumes of 2x SSC and hybridisation buffer for at 
least 30 min while the microscope slide was placed horizontally in a humid chamber (stainless 
steel grid in a stainless steel box containing DEPC-treated H2O at the bottom). Prior to the 
application of the mixture the slide was dried with paper tissue omitting the section 
generously to minimise dilution effects. 
One aim of the prehybridisation is to saturate nonspecific sites that might adsorb probe 
molecules. This saturation is achieved by subjecting the sections to macromolecules such as 
Denhardt's solution, RNA or DNA contained in the hybridisation buffer. However, no probe 
is added. 
Option 3: The sections were subjected to a dehydrating alcohol series (50%, 70%, 90%, and 
100% ethanol) for 5 min each and then air dried. This eliminates any dilution of the 
subsequently applied hybridisation buffer with probe. 
2.5.4 Hybridisation 
In situ hybridisation is the step during which the target nucleic acid, having been rendered 
accessible by pretreatments to the probe, will be capable of hybridising with this probe in 
given conditions. For this purpose, the probe has to be complimentary, thus anti-sense, to the 
target nucleic acid. A successful hybridisation is characterised by the formation of stable and 
specific hybrids. Crucial for a successful hybridisation is the choice of hybridisation buffer, 
hybridisation temperature, Na+ concentration, type of probe and length of probe. The 
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composition of the hybridisation buffer was based on the protocol of Molenaar et al. (1992) 
with some minor adjustments for non-radioactive probes and is shown in Table 2.5. The 
salinity of this buffer was 0.54 M and the hybridisation temperature was 52°C. As a reminder, 
three DIG labelled RNA probes were tested: bHp1 (174 nt), bHp2 (302 nt), and hHp (338 nt). 
In addition, different total amounts of probe were tested: 10 to 60 ng per section for the 
standard ISH and 3 to 30 ng per section for ISH with the TSA (see below). 
The probe was applied to the section as follows: After thawing the probe on ice, the 
appropriate amount was added to the hybridisation buffer to yield a total volume of 50 µl. 
This solution was mixed gently, but thoroughly because of the viscosity of the buffer. Next, 
this mixture was exposed to 80°C for 5 min to denature the RNA probe and then immediately 
placed in ice to preserve the denatured structure. Following the final step of pretreatment, the 
slide was dried with paper tissue omitting the actual section. Then the section was carefully 
overlaid with 50 µl of the hybridisation mixture and covered with a Hybri-Slip (40 mm x 
24 mm) cut in half. Finally, the slide was placed horizontally in a humid chamber filled with 
DEPC-treated H2O and incubated at 52°C overnight (16 to 18 h). 
Tab. 2.5: Reagents of hybridisation buffer. 
Reagent Concentration Purpose 
Dextran sulphate 10% 
A nonionic polymer, it increases the effectiveness of 
hybridisation by accelerating the reaction through 
concentrating the solute through the volume that it 
occupies in the solution. It also has considerable 
blocking activity. 
Formamide, 
deionised 50% 
It reduces the hybridisation temperature necessary for 
the hybridisation to take place and, thus, preserves 
better tissue morphology. 
NaCl 150 mM Hybrids form in the presence of Na
+ ions. Their con-
centration has a direct effect on their stability. 
SSC 2x As for NaCl 
Yeast tRNA 0.2 mg/ml Macromolecules that produce saturation of nonspecific bonds by competition, hence its high concentration. 
Fish sperm DNA 1 mg/ml As for yeast tRNA 
Denhardt's 
solution 1x 
Macromolecules also saturating nonspecific bonds by 
competition 
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2.5.5 Posthybridisation washes 
The main aim of the posthybridisation washes is to increase the specificity of the 
hybridisation signal or, in other words, to reduce background by removing probe that has 
bound unspecifically or not at all. This can be achieved by controlling temperature and 
salinity of washing buffer as well as including RNase treatment. 
After the hybridisation step the Hybri-Slips were rinsed off by carefully flushing 2x SSC with 
a pipette between slip and slide and the slides were placed in a Hellendahl glass jar filled with 
2x SSC. The sections were washed twice in 2x SSC at 45°C for 10 min each, twice in 50% 
formamide/50% 2x SSC at 45°C for 10 and 20 min, respectively, and, finally, twice in 0.2x 
SSC on the shaker (100 rpm) at room temperature for 10 min each.  
Next, sections were subjected to an RNase digest. Two different types of enzymes (RNase A, 
RNase T1), their combination and different enzyme concentrations were tested in 2x SSC 
buffer during 30 min at 37°C, based on the literature (Yang et al., 1999; Goldammer et al., 
2004; Lavery et al., 2004):  
1. 10 µg RNase A/ml 
2. 10 µg RNase A + 100 U RNase T1/ml 
3. 5 µg RNase A + 50 U RNase T1/ml 
4. 5 µg RNase A + 25 U RNase T1/ml 
5. without RNase. 
Option 3 (5 µg RNase A + 50 U RNase T1/ml) returned results optimal for the purpose of this 
study. The digest was followed by three washes in 2x SSC on the shaker (100 rpm) for 10 min 
each. Extra care was taken during the handling of RNase to avoid any undesirable 
contaminations in the laboratory. 
2.5.6 Revelation of hybrid 
2.5.6.1 Immunological detection of hybrid without signal amplification 
Generally, the choice of the revelation method depends on the type of hybrid label. The DIG 
labelled probe used in this study was detected immunologically by an anti-DIG antibody 
coupled with alkaline phosphatase which in turn reacts with the substrate NBT/BCIP. 
Phosphatase hydrolysis of BCIP is coupled to the reduction of NBT, yielding a formazan and 
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an indigo dye that together form a black-purple coloured precipitate at the site of reaction (see 
Figure 2.2). 
DIG
AP
NBT/BCIP
target mRNA
mRNA
Dig labelled RNA probe
AP labelled anti-DIG antibody
Substrate
Enzyme catalyses
 
Fig. 2.2: Diagram of hybrid detection system. 
 
The effects of two kinds of substrate buffer were compared (substrate buffer 1 and 2). 
Substrate buffer 2 contained 50 mM MgCl2 in addition to substrate buffer 1. This was 
recommended in older protocols and explained with the need for Mg of the enzyme AP for 
optimal activity. However, meanwhile it is suggested that endogenous Mg present in the 
section is sufficient (personal communication with technical support at Roche) and was 
confirmed herein. Furthermore, the effect of adding 1 mM or 5 mM levamisole to the staining 
solution was considered (Roche, 2002; Goldammer et al., 2004), which is supposed to 
inactivate endogenous phosphatase. Since no significant background staining was obtained 
when exposing the sections to all steps without the addition of probe and without the addition 
of levamisole, this option was abandoned.  
Similarly to the probe quantification by dot blot, the combination of NBT and BCIP were 
used as substrates. Staining of bluish, brownish or purplish colour was considered as specific 
ISH staining. 
The following steps were conducted: 
• MA buffer, 10 min (equilibration) 
• 1% blocking solution (10% blocking reagent diluted 1:10 in MA buffer), 30 min with 
agitation (100 rpm) 
• Slides were dried with a tissue adjacent to the sections, the sections encircled with a 
special pen (PAP Pen Super) creating a water repellent barrier 
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• 100 µl Anti-DIG-AP antibody (Fab fragment, Roche), diluted 1:500 in 1% blocking 
solution, in a humid chamber in the dark for 2 h at room temperature 
• MA buffer containing 0.1% Tween 20, 15 min, with agitation (100 rpm) (wash off 
excessive antibody) 
• MA buffer, three times 15 min, with agitation (100 rpm) (washes) 
• Substrate buffer 1 or 2, 10 min (equilibration) 
• Substrate incubation (final concentration: 337.5 µg NBT/ml, 175 µg BCIP/ml in 
substrate buffer 1 or 2; i.e. 225 µl NBT + 175 µl BCIP in 50 ml substrate buffer), 
protected from light, 2 h or more, mainly overnight, until optimal staining achieved; 
addition of 1 mM or 5 mM levamisole was tested 
• TE buffer, 10 min (termination of substrate reaction) 
• Mounting with Kaiser's glycerol gelatine 
2.5.6.2 Immunological detection of hybrid with signal amplification 
Strong specific staining was observed for Hp mRNA in liver tissue with the above described 
protocol, whereas this could not be achieved in mammary gland sections. This pointed to low 
levels of Hp mRNA expression in that tissue, but also emphasised the need for signal 
enhancement integrated into the ISH protocol. In this study two options were investigated: 
polyvinyl alcohol (PVA) as supplement to the staining solution as described above, and the 
inclusion of the tyramide signal amplification (TSA) system as an additional step during the 
revelation process.  
Polyvinyl alcohol 
As part of the staining solution, PVA can reduce the diffusion of reaction intermediates by 
enhancing the formazan formation during the phosphatase reaction and, thus, is leading to an 
increase in signal sensitivity up to 20-fold without increasing background (De Block and 
Debrouwer, 1993). 
Following equilibration in standard substrate buffer, the sections incubated in PVA-substrate 
buffer plus substrates (337.5 µg NBT/ml, 175 µg BCIP/ml) at 30°C. When colour 
development was optimal, slides were washed thrice for 5 min in ultra-pure H2O, the sections 
then dehydrated once in 70% ethanol and twice in 100% ethanol 15 sec each and finally 
mounted with Kaiser's glycerol gelatine. 
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Tyramide signal amplification 
Tyramide is a phenolic compound that precipitates after oxidation. It can be labelled and its 
label, in this study dinitrophenol (DNP), can be detected immunologically in a similar manner 
as described above. The principle of TSA-DNP technology is that several DNP molecules are 
coupled to each single tyramide molecule. Therefore, after oxidation of TSA by the enzyme 
peroxidase, numerous DNP labels are deposited immediately adjacent to the site of the 
enzyme and, consequently, a higher number of substrate molecules can be precipitated at the 
site of detectable mRNA in comparison to the standard immunological detection (see Figure 
2.3). 
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Fig. 2.3: Diagram of the hybrid detection system including tyramide signal 
amplification. 
 
The TSA Plus DNP AP system was integrated after the posthybridisation washes and carried 
out according to the manufacturer's instruction (PerkinElmer LAS). As also recommended by 
the manufacturer and suggested by Yang et al. (1999), different incubation times and reagent 
dilutions had to be adapted for this study:  
• TN buffer, 5 min 
• Encircle section with PAP Pen Super 
• 100 µl TNB blocking buffer, 30 min 
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• 90 µl Anti-DIG-POD antibody (Fab fragment, Roche) diluted 1:100 or 1:500 in TNB 
blocking buffer, protected from light, 30-60 min 
• TNT wash buffer, three times 5 min with agitation (100 rpm) 
• 90 µl TSA Plus DNP working solution (DNP amplification reagent stock solution 
diluted 1:50 in 1x Plus Amplification diluent (TSA kit)), 3 or 10 min 
• TNT wash buffer, three times 5 min with agitation (100 rpm) 
• 90 µl Anti-DNP-AP (TSA kit) diluted 1:100 in TNB blocking buffer, protected from 
light, 30-60 min 
• TNT wash buffer, three times 5 min with agitation (100 rpm) 
• Substrate buffer 1, 10 min 
• Substrate (337.5 µg NBT/ml, 175 µg BCIP/ml substrate buffer 1), protected from 
light, 10-50 min 
• TE buffer, 10 min 
• Mounting with Kaiser's glycerol gelatine. 
Optimal results were produced by the 1:100 dilution of the Anti-DIG-POD antibody, longer 
incubation times of both antibodies (60 min) as well as the TSA Plus DNP working solution 
(10 min) and substrate incubation for 50 min. 
2.5.7 Counterstaining 
Two types of counterstaining were tested. First, sections were exposed to 0.1% Nuclear Fast 
Red in 5% aluminium sulphate for 1 min, washed twice in tap water for 10 min. Alternatively, 
sections were placed in Mayer's hemalum solution for 3-5 sec, followed by 1% potassium 
aluminium sulphate for 10 sec to stop the staining reaction and washed briefly in ultra-pure 
H2O. These steps were applied after the substrate reaction was completed, but before sections 
were mounted with Kaiser's glycerol gelatine. The reactions lead to a red or blue staining of 
the nucleus, respectively. Both procedures were sourced from Roche (Roche (2002) and 
personal communication with their technical support, respectively). 
2.5.8 Evaluation and scoring of the ISH staining signals 
The staining of the sections was assessed by light microscopy (Microscope DM LB, Leica). In 
addition, the staining of each section was scored evaluating one section per tissue: A 
reference grid (1 x 1 cm; 10 x 10 squares) placed in the microscope ocular was superimposed 
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over the section, and stained cells of 24 squares (randomly picked for the grid, but fixed for 
all sections) were counted at a total magnification of 260. 
Instruments for photographing (Routine microscope, Axioskop 2 MOT, Zeiss; Polaroid DMC 
Ie camera) were kindly made available by PD Dr. Stephan Baader. 
2.5.9 Controls 
2.5.9.1 Negative controls 
Hybridisation without probe 
In order to control background staining, the complete ISH reaction was carried out without 
the addition of probe to the hybridisation buffer. This tool represents a negative control and is 
of particular use when working with signal amplification systems such as TSA. 
Application of sense probe 
The sense probe serves as another negative control. Since its sequence is identical to the target 
mRNA, it does not attach to the target mRNA and, thus, is not leading to staining. For all 
treatments tested, a section hybridised with sense probe was always prepared in parallel to 
each section hybridised with antisense probe. The "sense section" was semi-adjacent to the 
"antisense section". 
2.5.9.2 Positive controls 
Casein probe 
Casein is a protein that is widely synthesised in the alveolar epithelium of the lactating 
mammary gland (Molenaar et al., 1992). In situ hybridisation with an RNA probe for this 
protein applied to cryosections of bovine mammary gland served as positive control in this 
study to be able to demonstrate the functioning of ISH in this organ. Both as and s probes 
(750 and 850 nt, respectively) originated from amplifications of plasmid inserts which had 
been kindly donated by Prof. Dr. Hans-Martin Seyfert, Research Institute for the Biology of 
Farm Animals, Dummerstorf, Germany. Prior to this study, these probes had been tested 
successfully in the same laboratory by Claudia Hakemann during her PhD studies in an ISH 
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applied to paraffin embedded sections (Hakemann, 2002). Her protocol was adapted for the 
current study with cryosections.  
Liver tissue 
ISH with bovine liver cryosections served as positive control for all three Hp probes produced 
since this organ is the main site of Hp synthesis.  
2.6 Measurement of Hp protein in blood and milk 
The Hp protein concentration was determined in the serum and milk samples of the Hanover 
cows by enzyme linked immunosorbent assay (ELISA). The assay (Hiss et al., 2004) was 
slightly modified such that serum Hp was applied for coating and standard curve instead of 
Hp purified from bovine serum. The standard used herein had been calibrated against a 
standard obtained from European Union Concerted Action on the standardisation of animal 
APP (QLKS-T-1999-0153). 
2.7 Statistical analysis 
The data from both the ISH signal scoring and the Hp protein analysis were analysed by a 
nonparametric paired samples test (Friedman's test) in SPSS 12.0. A p-value < 0.05 was 
considered significant. 
 
 3 Results 
3.1 Detection of Hp mRNA in blood and milk somatic cells 
of cattle and man as well as in human mammary gland 
by RT-PCR 
3.1.1 Blood and milk somatic cell preparation 
When isolating leukocytes initially with a heparin concentration of 10,000 IU/l blood, the first 
centrifugation step produced a buffy coat with cells adhering too strongly to allow proper 
subsequent isolation. Similar difficulties were observed when increasing heparin 
concentration to 15,000 IU/l. Finally, best results were achieved with 5000 IU heparin/l 
blood. No difficulties occurred when preparing milk somatic cells.  
The process from blood or milk sampling until freezing of the final cell pellet to extract RNA 
from required 4 h maximally. 
3.1.2 Blood cells – differential count, number and viability  
The differential cell count of the whole blood samples from the six Frankenforst (F) cows and 
the four humans are presented in Table 3.1, all being close to the normal range for their 
species. The number of isolated leukocytes varied between 8 to 152 x 106 cells from 48 ml 
whole blood, and the number of isolated cells per MNC and PNC fraction varied between 36 
to 62 x 106 cells originating from 45 ml whole blood (Table 3.2). The extracted cells showed 
a viability above 85%. The purity of five MNC and PNC fractions was greater than 94%, 
while the PNC fraction of cow F6 contained 85% polymorphonuclear and 15% mononuclear 
cells (Table 3.2). The contamination of isolated white blood cells with erythrocytes was 
established in the counting chamber and was less than 2% for all samples. This contamination 
was not taken into account when assessing composition of isolated fractions (Table 3.1). 
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Tab. 3.1: White blood cell differential of six cows and four humans. 
Candidate Lymphocytes 
(%) 
Monocytes 
(%) 
Neutrophils 
(%) 
Eosinophils 
(%) 
Basophils 
(%) 
Cow F1 70 7 18 4 1 
Cow F2 58 2 26 14 0 
Cow F3 67 2 29 2 0 
Cow F4 58 0 36 6 0 
Cow F5 60 2 30 8 0 
Cow F6 71 2 27 0 0 
Normal range 
for cattle(1) 45-65 2-6 25-45 1-10 0-2 
Volunteer 1 34 0 64 2 0 
Volunteer 2 41 1 57 1 0 
Volunteer 3 29 0 70 1 0 
Volunteer 4 25 0 72 3 0 
Normal values 
for man(2) 31 6 60 2 <1 
    (1) Kraft and Dürr (1999); (2) Klinke and Silbernagel (1994) 
Tab. 3.2: Number and viability of isolated blood cell fractions and where applicable 
their composition.  
Fraction composition Candidate Isolated 
blood cell 
fraction 
Number of 
separated cells 
per fraction  
(x 106) 
Cell 
viability 
(%) 
MNC (%) PNC (%) 
Cow F1 leukocytes 48 95 - - 
Cow F2 leukocytes 152 91 - - 
Cow F3 leukocytes 136 99 - - 
Cow F4 MNC 52 85 98 2 
Cow F4 PNC 46 99 4 96 
Cow F5 MNC 49 90 95 5 
Cow F5 PNC 49 93 4 96 
Cow F6 MNC 62 89 94 6 
Cow F6 PNC 36 93 15 85 
Volunteer 1 leukocytes 25 94 - - 
Volunteer 2 leukocytes 11(1) 96 - - 
Volunteer 3 leukocytes 8 100 - - 
Volunteer 4 leukocytes 12 97 -  
     (1) Only 24 ml whole blood were available from volunteer 2. 
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3.1.3 Milk somatic cells 
Since there was no cell count and smear carried out with the extracted milk cells, there are no 
results available for the parameters cell count, viability and differential in milk.  
3.1.4 Quality of extracted total RNA 
Figure 3.1 illustrates the gel electrophoresis results from a representative selection of blood 
and milk somatic cell RNA samples. Two bands were visible in all samples representing the 
28S and 18S rRNA subunits. The fluorescence intensity of the 28S band was twice the 
intensity of the 18S band in three samples (lane 2, 3 and 5) whereas of approximately 
identical intensity in the other three samples (lane 1, 4 and 6).  
It must be noted that the total amount of extracted RNA from PNC (2.3-4.6 µg) was around 
ten-fold lower compared to MNC (39.5-60.0 µg). Considering that per sample 1 µg RNA was 
required for each cDNA synthesis (two preparations: with and without the transcriptase 
enzyme), the amount of PNC RNA was insufficient to also allow RNA gel electrophoresis. 
Priority was given to cDNA synthesis.  
28S rRNA
18S rRNA
1 2 3 4 5 6
Fig. 3.1: Denaturing gel electrophoresis of RNA extracted from blood cells (lane 1 to 3) 
and milk somatic cells (lane 4 to 6). 
 
3.1.5 Qualitative RT-PCR results 
3.1.5.1 Bovine leukocytes  
The leukocytes of all three cows examined showed a distinct RT-PCR signal for bHp 
(174 bp), while the same samples subjected to RT-PCR without reverse transcriptase did not 
yield any signal (Figure 3.2). The controls (liver and water with bHp primers as positive and 
negative control, respectively, as well as all samples with β-actin primers as internal control) 
worked as required. 
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Fig. 3.2: Qualitative RT-PCR detection of bovine Hp mRNA (174 bp) in bovine blood 
leukocytes (A) parallel to the detection of β-actin mRNA (226 bp) as internal 
control in the same cells (B). Lanes F1-F3 contain PCR products of RNA from 
three individual Frankenforst cows. The same RNA samples underwent RT-
PCR without the addition of reverse transcriptase (lanes F1'-F3'). Mk = mar-
ker, L = bovine liver (positive control), W = water control. 
 
 
3.1.5.2 Bovine mononuclear and polymorphonuclear blood cells 
Figure 3.3 shows the RT-PCR results of bHp mRNA in bovine MNC and PNC. In both 
leukocytes subpopulations a clear signal was found for the Hp gene, though the signals of cow 
F6 were of weaker intensity. The RT-PCR controls as described above for blood leukocytes 
worked successfully. 
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Fig. 3.3: Qualitative RT-PCR detection of bovine Hp mRNA (174 bp) in bovine blood 
MNC and PNC (A) parallel to the detection of β-actin mRNA (226 bp) as inter-
nal control in the same cells (B). Lanes F4-F6 contain PCR products of RNA 
from three individual Frankenforst cows each of whose leukocytes were divided 
into mononuclear cells (M) and polymorphonuclear cells (P). The same RNA 
samples underwent RT-PCR without the addition of reverse transcriptase 
(lanes F4'-F6'). Mk = marker, L = bovine liver (positive control), W = water 
control. 
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3.1.5.3 Bovine milk somatic cells 
In bovine milk somatic cells, distinct RT-PCR fragments for the bHp gene were found, 
though the bHp signal for cow F7 was of weaker intensity compared to the other two cows 
(Figure 3.4). Similarly for cow F7, the internal control gene β-actin showed a slightly weaker 
signal. This suggests that RNA extracted from this animal's milk might generally have been of 
minor quality, which would also explain the results for the bHp gene. The RT-PCR controls 
worked as desired. 
 
603 bp
310 bp
281 bp
234 bp
194 bp
271 bp
A
B
F7 F8 F9 L F7' F8' F9'
bovine milk somatic cells
WMk
bHp
β-actin
Fig. 3.4: Qualitative RT-PCR detection of bovine Hp mRNA (174 bp) in bovine milk 
somatic cells (A) parallel to the detection of β-actin mRNA (226 bp) as internal 
control in the same cells (B). Lanes F7-F9 contain PCR products of RNA from 
three individual Frankenforst cows. The same RNA samples underwent RT-
PCR without the addition of reverse transcriptase (lanes F7'-F9'). Mk = mar-
ker, L = bovine liver (positive control), W = water control. 
 
3.1.5.4 Human leukocytes 
The leukocytes of all four human candidates did not present a hHp signal after applying the 
standard RT-PCR method (Figure 3.5, A). However, hHp specific transcripts (338 bp) were 
found after reamplification of the first course PCR products, but only in two out of four 
individuals (Figure 3.5, B). Standard RT-PCR detected β-actin transcripts in samples of all 
four donors (Figure 3.5, C). RT-PCR and reamplification without the addition of reverse 
transcriptase did not produce any signal for the Hp as well as the β-actin gene in all samples. 
This emphasizes that no contaminating genomic DNA had been present in the RNA samples 
used, which in turn suggests that the positive results seen after reamplification originate from 
Hp mRNA present in the samples. Also RT-PCR and reamplification of the positive and 
negative PCR controls, liver and water respectively, presented results as required. 
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Fig. 3.5: Qualitative detection of human Hp mRNA (338 bp) in human blood leukocytes 
after RT-PCR (A) and reamplification of 1 µl of these first course RT-PCR pro-
ducts (B), parallel to the standard RT-PCR detection of β-actin mRNA (226 bp) 
as internal control in the same cells (C). Lanes 1-4 contain PCR products of 
RNA from four individual test persons. The same RNA samples underwent RT-
PCR and reamplification without the addition of reverse transcriptase (lanes 
1'-4'). Mk = marker, L = human liver (positive control), W = water control. 
 
 
3.1.5.5 Human mammary gland 
Figure 3.6 illustrates RT-PCR products of Hp mRNA in human mammary gland alongside 
human liver as control organ. The other RT-PCR controls (water with hHp primers as well as 
all samples with β-actin primers) worked as required. 
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281 bp
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Fig. 3.6: Qualitative RT-PCR detection of human Hp mRNA (338 bp) in human mam-
mary gland (MG) (A) parallel to the detection of β-actin mRNA (226 bp) as 
internal control in the same cells (B). Mk = marker, L = human liver (positive 
control), W = water control. 
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3.2 Cellular localisation of Hp mRNA in infected bovine 
mammary glands by ISH 
3.2.1 Establishment of suitable ISH protocols 
3.2.1.1 ISH controls 
Casein mRNA was detected in bovine mammary gland tissue by a ISH protocol which was 
based on the study by Hakemann (2002). However, modifications were necessary since the 
current research was carried out with cryosections instead of paraffin embedded sections. 
Also minor changes were made to the order of the pretreatments and the composition of some 
buffers to fit in with the ISH procedures with Hp probes. The detailed protocol is presented in 
the appendix.  
Hp mRNA was detected in bovine liver tissue by in situ hybridisation with all three probes, 
however best results were achieved applying bHp2 probe by the protocol also given in the 
appendix.  
3.2.1.2 Hp mRNA in the bovine mammary gland 
The finally established protocol for best detection of Hp mRNA in the bovine mammary 
gland is presented in the appendix. The three key elements of this protocol were: 
1. Omission of deproteinisation 
2. Introduction of the longer homologous bHp2 probe 
3. Introduction of TSA 
Overall, implementing the longer bHp2 probe into the ISH protocol applied to bovine liver 
(omitting deproteinisation) had generated hybridisation signals noticeably stronger than with 
the bHp1 probe. Likewise, with a previous protocol, still containing a deproteinisation 
pretreatment, the heterologous hHp probe had returned similarly weak staining results as the 
bHp1 probe in the bovine liver, therefore the homologous probes were preferred. In summary, 
bHp2 was the probe of choice.  
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Most importantly for the detection of Hp mRNA in the bovine mammary gland was the 
introduction of signal amplification by the TSA system to an existing ISH protocol with 
which Hp mRNA had already been established for bovine liver with no deproteinisation and 
employment of the bHp2 probe. It caused a marked increase in signal intensity, whereas the 
addition of PVA to the substrate buffer produced no noticeable signal enhancement. These 
staining signals produced by the TSA appeared to be even more distinct, i.e. with less 
background, when including alcohol series after fixation. Moreover, when initially 
establishing the ISH protocol with the TSA system, the amount of 3 ng probe/section had 
generated equally good staining as the amount of 30 ng probe/section, which is why the lesser 
amount was applied subsequently to save probe. 
Finally, neither haemalaun nor Nuclear Fast Red treatments produced counterstains of 
satisfying contrast to the NBT/BCIP reaction products. Therefore, it was refrained from this 
option. No attempt had been undertaken to optimise the protocols further for the current 
purposes. 
3.2.2 Demonstration of ISH results  
3.2.2.1 ISH controls 
With the established ISH protocols the following results were achieved for the ISH controls: 
Distinct staining for casein mRNA was detected in the alveolar epithelium and no signal in 
the stroma of the mammary gland. The section hybridised with the sense probe remained 
unstained (Figure 3.7; A, A'). 
Strong ISH signals were found in hepatocytes but no staining in stroma, bile duct and blood 
vessels. Also no staining was present in liver sections hybridised with the sense probe (Figure 
3.7; B, B'). 
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Fig. 3.7: Controls for ISH: Detection of casein mRNA in bovine mammary epithelium 
(A) and of Hp mRNA in bovine liver hepatocytes (B). Tissues were hybridised 
with antisense (A, B) and sense probe (A', B'). Bars represent 100 µm. 
 
3.2.2.2 Hp mRNA in infected bovine mammary glands 
All control sections, i.e. sections of the bovine mammary gland incubated with bHp2 sense 
probe (see Figure 3.8 (A' to D'), Figure 3.9 (A' to D') and Figure 3.10 (A')) or without any 
probe (data not shown), were devoid of any specific hybridisation signal. 
Hp mRNA was visualised in the alveolar epithelium cells of bovine mammary glands by ISH 
with bHp2 antisense probe. Specific signals for Hp mRNA were found in udders previously 
infected with E. coli as well as glands infected with Staph. aureus; however, the two 
treatment groups exhibited markedly different staining patterns. Figures 3.8 and 3.9 present 
the results of one cow per treatment group.  
In E. coli infected cows, the number of cells stained per mammary alveolus was low in the 
control quarter (Figure 3.8; A) and increased with increasing incubation time of the pathogen 
in the other quarters (Figure 3.8; B to D). In detail, while Hp mRNA was demonstrated only 
in single cells scattered across the section of the control quarter, the stained cells appeared in 
patches of isolated areas of adjacent alveoli after 6 h incubation time. The size of these areas 
expanded further in quarters infected for 12 h, until the staining was uniformly distributed in 
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the section of the quarter exposed to E. coli for 24 h. This pattern of Hp expression was 
repeated in the samples of the other E. coli cows.  
Mammary glands infected with Staph. aureus, in contrast to E. coli treated udders, showed a 
minimal level of Hp mRNA expression detected by ISH with slight variations between the 
three cows in this treatment group. Sections of quarters of the first cow infected at T0 and at 
T18 with Staph. aureus or having received only saline were completely devoid of any positive 
Hp mRNA signal (Figure 3.9; A, B, D), while a small number of stained epithelium cells was 
present in the T12 quarter (Figure 3.9; C). In fact, the hybridisation signals in the sections of 
this quarter were confined only to those cells depicted in this photo. Similarly for one other 
cow of the same treatment group, ISH signal was restricted to a patch of few stained cells in 
sections from also one single quarter only, namely the quarter treated with saline. The other 
three quarters of that cow remained without a positive ISH signal (data not shown). Moreover, 
the sections of the third cow were even completely devoid of any ISH signal (data not 
shown). 
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Fig. 3.8: Localisation of Hp mRNA expression in bovine mammary gland epithelium by 
in situ hybridisation (purple stained cells). Three udder quarters had been in-
fected intracisternally with E. coli at 6 (B, B'), 12 (C, C'), and 24 h (D, D') pre-
slaughter, the fourth quarter had received saline as control 24 h pre-slaughter 
(A, A'). Tissue was hybridised with antisense (A to D) and sense probe (A' to 
D'). Bars represent 50 µm. 
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Fig. 3.9: Localisation of Hp mRNA expression in bovine mammary gland epithelium by 
in situ hybridisation (purple stained cells). Three udder quarters had been in-
fected intracisternally with Staph. aureus at 6 (B, B'), 12 (C, C'), and 24 h (D, 
D') pre-slaughter, the fourth quarter had received saline as control 24 h pre-
slaughter (A, A'). Tissue was hybridised with antisense (A to D) and sense 
probe (A' to D'). Bars represent 50 µm. 
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The differences in mammary Hp mRNA expression between the two treatment groups 
assessed by quantifying stained cells with the aid of a reference grid is summarised in Table 
3.3. The number of stained cells per section differed significantly between the four quarters 
infected with E. coli for varying lengths of time: the quarter infected for 24 h showed 
considerably more stained cells than the quarters treated with saline or infected for 6 h and 
even 12 h. In contrast, all of the corresponding figures for the Staph. aureus treated cows 
were extremely low or even zero and remained unchanged over the experimental period.  
Tab. 3.3: Abundance of Hp mRNA in the bovine mammary gland visualised by ISH was 
quantified by counting ISH staining signals via a reference grid (stained 
cells/square). Cows were infected intramammarily by E. coli (n = 3; EC1 to 
EC3) or Staph. aureus (n = 3; SA1 to SA3), the four quarters of each were ex-
posed to the pathogens for varying lengths of time pre-slaughter (0, 6, 12 and 
24 h, respectively). Mean values (± sem) per treatment group are also given.  
Cow Duration of infection per quarter p-value 
 0 h 6 h 12 h 24 h  
EC1 0.2 0.3 0.4 26.3  
EC2 0 0 0 18.3  
EC3 0.8 1.1 4.7 6.8  
Mean ± sem 0.3 ± 0.2 0.5 ± 0.3 1.7 ± 1.5 17.1 ± 5.7 < 0.05 
SA1 0.04 0 0 0  
SA2 0 0.13 0 0  
SA3 0 0 0 0  
Mean ± sem 0.01 0.04 0 0 > 0.05 
 
In addition to the alveolar epithelium, Hp mRNA was also expressed in the multilayered milk 
duct epithelium. This evaluation was possible because milk ducts were found in some sections 
prepared from the secretory tissue. Figure 3.10 (A, A') shows results from a quarter infected 
with E. coli for 12 h; single cells of the epithelium with ISH staining were also observed in a 
quarter infected for 24 h (data not shown). In contrast, no staining occurred in a quarter 
treated with Staph. aureus for 24 h (Figure 3.9; D). No attempt was undertaken to assess the 
expression in milk ducts of other quarters. 
Next to parenchymal cells, also some cells within the stroma presented ISH specific staining 
for Hp mRNA (Figure 3.10; B1, B2). Their presence was limited to the sections derived from 
E. coli cows only and therein to no more than two cells per section. Identification of those 
cells was not possible since counterstaining could not be optimised. 
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Fig. 3.10: Localisation of Hp mRNA expression in milk duct (A) and stroma (B1, B2; 
arrows) of the bovine mammary gland by in situ hybridisation. Quarter had 
been infected with E. coli 12 h pre-slaughter. Tissue was hybridised with anti-
sense (A, B1, B2) and sense probe (A'). Bars represent 50 µm.  
 
3.3 Hp protein concentration in blood and milk of dairy 
cows affected by mastitis 
Hp concentration in serum differed significantly between samples collected from E. coli cows 
at four time points during the 24 h infection period, which is in contrast to samples from 
Staph. aureus cows (Table 3.4). Pre-stimulus values were numerically similar in both 
treatment groups; however, blood Hp concentration rose 55-fold but only 2-fold during 24 h 
of infection by E. coli and Staph. aureus, respectively. Likewise, milk samples collected from 
the four quarters of the E. coli cows immediately prior to slaughter showed a significant 
difference in their Hp concentration, but no significant changes of Hp concentrations were 
observed in milk from quarters affected by Staph. aureus (Table 3.5). The Hp concentration 
in milk from quarters exposed to E. coli for 24 h was 165-fold higher than in the control 
quarter.  
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Tab. 3.4: Hp concentration (µg/ml) in serum from six cows before and during the course 
of experimental intramammary infection with E. coli (EC1 to EC3) or Staph. 
aureus (SA1 to SA3). Three quarters of each cows were inoculated at 0, 12 and 
18 h, respectively. Cows were slaughtered after 24 h. Mean values (± sem) per 
treatment group are also given. 
Cow Time since initial intramammary infection p-value 
 0 h 12 h 18 h 24 h  
EC1 27.8 35.8 221.0 1040.0  
EC2 18.2 22.6 76.8 785.0  
EC3 12.0 50.0 55.0 1410.0  
Mean ± sem 19.3 ± 4.6 36.1 ± 7.9 117.6 ± 52.1 1078.3 ± 181.4 < 0.05 
SA1 22.7 23.7 35.1 19.9  
SA2 23.1 35.5 43.4 135.0  
SA3 24.0 31.0 25.0 10.0  
Mean ± sem 23.3 ± 0.4 30.1 ± 3.4 34.5 ± 5.3 55.0 ± 40.1 > 0.05 
 
Tab. 3.5: Hp concentration (µg/ml) in quarter milk from six cows at slaughter previous-
ly infected intramammarily with E. coli (EC1 to EC 3) or Staph. aureus (SA 1 
to SA3). The four quarters were exposed to the pathogens for varying lengths 
of time pre-slaughter (0, 6, 12 and 24 h, respectively). Mean values (± sem) per 
treatment group are also given. 
Cow Duration of infection per quarter p-value 
 0 h 6 h 12 h 24 h  
EC1 2.0 2.5 8.1 294.0  
EC2 4.1 2.7 45.4 433.0  
EC3 2.0 5.0 114.0 642.0  
Mean ± sem 2.7 ± 0.7 3.4 ± 0.8 56.5 ±30.9 456.3 ± 101.1 < 0.05 
SA1 0 0 0 0  
SA2 2.9 5.1 2.8 1.8  
SA3 5.0 1.0 2.0 4.0  
Mean ± sem 2.6 ± 1.4 2.0 ± 1.6 1.6 ±0.8 1.9 ± 1.2 > 0.05 
 
 
 4 Discussion 
4.1 Discussion of the methods applied 
4.1.1 Isolation of blood and milk somatic cells and subsequent 
RNA extraction for RT-PCR 
Effect of blood and milk processing on Hp mRNA expression 
The cell isolation process, i.e. taking blood or milk samples until freezing the final cell pellet 
for RNA extraction, required up to 4 h. This delay might have had an enhancing effect on Hp 
mRNA expression: Duvigneau et al. (2003) showed with porcine peripheral immune cells a 
significant increase in mRNA expression of both cytokines IL-1 and IL-6 in these cells 6 h 
after sampling compared to processing immediately or after 1 or 2 h. Assuming a similar time 
course in cattle and man and knowing that Hp synthesis in both species can be primed by IL-6 
(Baumann and Gauldie, 1994; Yoshioka et al., 2002) as well as that the effects of IL-6 can 
even be enhanced by IL-1 (Heinrich et al., 1990), the amount of Hp mRNA in the isolated cell 
populations might have been affected by the processing time in both species. On the other 
hand, it might be speculated that bovine leukocytes are more strongly affected by the length 
of processing time with regards to Hp mRNA expression than human leukocytes. Since Hp is 
considered as a major APP in cattle, but not in man, the Hp transcription might be upregulated 
more quickly in bovine immune cells during the stress situation of cell isolation than in 
human immune cells. Such a triggered additional Hp mRNA expression would have to be 
preceded by transcription and translation of IL-6. However, as the duration of IL-6 translation 
and subsequent Hp transcription is not known in both species, the proportion of Hp mRNA 
expression caused by the processing delay cannot be precisely determined.  
Whether the processing time, besides affecting cytokine production, might also have a direct 
effect on Hp mRNA expression itself in blood or milk somatic cells was not discussed by 
Duvigneau et al. (2003). However, such an option cannot be excluded, although the 
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underlying mechanism is not known. Similarly, the effects of other processing parameters 
(e.g. sampling procedure, centrifugation speed, centrifugation temperature, laboratory 
temperature) on Hp mRNA expression in these cells could not be addressed in the current 
study.  
Leukocyte isolation 
The adherence of leukocytes by forming a firm buffy coat after initial centrifugation caused 
difficulties when using a heparin concentration of 10,000 IU/l or more. An increase in heparin 
concentration could not eliminate this problem as might be expected; instead best results were 
achieved with 5000 IU/l. Some researchers worked successfully with 10,000 IU/l (Duvigneau 
et al., 2003), while others managed with 2500 IU/l for leukocyte isolation (Dixit et al., 2003). 
Purity of isolated bovine MNC and PNC fractions 
Precise allocation of Hp mRNA to a single subpopulation isolated from bovine leukocytes is 
difficult due to the cross-contamination by cells of the other subpopulation of up to 5%, and 
in one sample even up to 15%. The use of fluorescence-activated cell sorting or magnetic 
bead sorting techniques might have produced cleaner cell populations, although low purity 
rates of only 78% have also been reported (Schubbert et al., 1997).  
It might be speculated that despite the cross-contamination the observed Hp mRNA 
expression in each fraction originates indeed from cells which were correctly allocated to their 
fraction. Bovine Hp mRNA production in the liver is known to be triggered by the presence 
of the cytokines IL-1, TNF-α or IL-6 (Yoshioka et al., 2002). Since these cytokines are 
reported to be generated in human monocytes (Hartel et al., 2004), bovine B-cells (Amills et 
al., 2004) and human polymorphonuclear granulocytes (Palma et al., 1992), they might also 
initiate Hp mRNA expression directly in all these leukocyte cell type in bovines. On the other 
hand, Hp mRNA expression in blood cells might occur without prior cytokine stimulus 
considering that these animals appeared healthy and not undergoing an acute phase. Likewise 
the option must be considered that a minority of cells contributes overproportionally to the 
amount of total Hp mRNA present. Both these latter possibilities impede a precise allocation 
of Hp mRNA expression to one cell type or subpopulation. 
RNA extraction: quality and total amount 
The quality of the RNA extracted from blood and milk somatic cells varied as assessed by gel 
electrophoresis. Only three out of the six presented samples showed strong 28S and 18S 
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rRNA bands; also only in the same three samples the intensity of the 28S band was twice that 
of the 18S band as is ideally the case (Ivell, 1998). This reflects that the quality of the 
extracted RNA in some samples was impaired. However, RNA, which showed both 28S and 
18S bands of identical intensity after gel electrophoresis, was also described to be of high 
quality (Chomczynski and Sacchi, 1987). Also, the gel electrophoresis visualises only the 
large rRNA subunits (28S ca. 5000 bp; 18S ca. 2000 bp; Alberts et al. (1997)). Considering 
that degradation of larger molecules is more likely than degradation of smaller molecules, 
smaller RNA units might still be intact in partially degraded total RNA. The Hp fragments to 
be detected ranged between 174 bp and 338 bp, and the fragment size of the control gene 
β-actin was 226 bp, all of which are considerably smaller than the rRNA subunits. In all 
samples β-actin fragments were present after RT-PCR, suggesting that indeed small RNA 
molecules were still intact in all samples used; yet, it must be noted that in the cells 
investigated the abundance of mRNA of the control gene β-actin was expected to be markedly 
higher than of the Hp gene. On the other hand, it has been demonstrated that gene expression 
profiles obtained from RNA samples, which were experimentally partially degraded to 
different extents, displayed a high degree of similarity to gene expression profiles from intact 
RNA samples (Schoor et al., 2003). These researchers concluded that RNA samples of 
suboptimal quality might still lead to meaningful results. In summary, it was assumed that the 
quality of the total RNA extracted from blood and milk somatic cells was adequate for the 
investigation of Hp mRNA presence by RT-PCR in the current study. 
The amount of RNA extracted from bovine MNC was approximately 10-fold that from PNC. 
This might be explained by the difference between the functions associated with these two 
cells fractions. The MNC fraction is dominated by lymphocytes whose main immune function 
is to produce antibodies, thus requiring a certain level of expression. In fact, memory cells, a 
kind of lymphocytes, can be active for years. In contrast, PNC consist mainly of 
polymorphonuclear granulocytes which have been characterised as terminally differentiated 
cells with insignificant RNA or protein synthesis, consistent with their limited quantity of 
ribosomes and endoplasmic reticulum (Cline, 1966; Bainton et al., 1971) and whose life span 
covers only a few days. In cattle, they circulate in the blood stream around 9 h and function as 
phagocytes in the mammary gland for 1 to 2 d (Van Oostveldt et al., 2001). 
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RT-PCR 
The method of RT-PCR worked successfully as demonstrated by the results of the PCR 
control samples. Possible methodical causes of the differences observed between the RT-PCR 
results from human and from bovine leukocytes are discussed below in chapter 4.2. 
4.1.2 ISH to detect Hp mRNA 
Tissue preparation and section fixation 
Tissue preparation is critical for the integrity of mRNA. For this work, tissue cubes were 
immediately excised after slaughter and snap frozen to prepare cryosections. Alternatively, 
paraffin embedded tissue can be used. The most important advantage of frozen tissue over 
fixed and paraffin embedded tissue is the higher preservation of intact mRNA which is 
essential when aiming at detecting low abundant target transcripts. A loss of up to 30% of 
RNA has been reported to occur during the process of tissue fixing and paraffin embedding 
(Jin and Lloyd, 1997; Roche, 2002). Moreover, a high level of RNase activity has been 
reported in rat mammary tissue (Liu et al., 1979), also emphasizing the need for suppressing 
RNase activity as rapidly as possible after tissue excision, in particular from mammary tissue. 
Therefore, since the number of Hp mRNA molecules was considered to be low in the bovine 
mammary gland, it was opted for preparing cryosections from snap frozen mammary tissue. 
However, common disadvantages of cryosections are, firstly, that more care has to be taken 
when handling frozen, thus not yet fixed tissue cubes and sections to minimise effects of 
possible active ribonucleases, secondly, the quality of morphology may considerably suffer 
during the preparation process and, finally, a section thickness of 10 to 20 µm may also 
interfere with optimal cellular localisation (Liu et al., 1998; Wilkinson, 1998). Sections from 
paraffin embedded tissue are usually obtained at a smaller thickness of 5 to 10 µm 
(Wilkinson, 1998).  
In addition, cryosections were always prepared on the day of use to avoid RNA losses during 
storage. While storage of cryosections is possible, e.g. dehydrated in an airtight box 
containing a drying agent (Wilkinson, 1998; Morel and Cavalier, 2000), signal intensity was 
reported to be inferior in desiccated sections stored at -80°C for two days (Yang et al., 1999). 
On the other hand, other researchers observed no signal losses when storing dehydrated 
cryosections for 5 to 7 d which had already been fixed in 4% PFA (Udovic, 1993; Köhler, 
2000). However, this option was not tested in the current study in order to minimise the 
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number of possible variables interfering with the ISH outcome. Instead, freshly prepared 
frozen sections underwent a fixation process immediately after cutting to stabilise the mRNA 
and to prevent RNase activity and were employed in the ISH immediately afterwards.  
Tissue pretreatment 
The main aim of treating the sections prior to hybridisation is to make the tissue permeable 
such that the target nucleic acid is rendered accessible to the probe. As already mentioned in 
the chapter "Materials and Methods" the literature reports a large variety of partly 
controversial options available to achieve this aim. One key finding when developing the 
present ISH protocol to detect Hp mRNA in mammary gland was that best staining results 
were yielded when omitting the entire deproteinisation step. This feature is consistent with 
protocols described by Jung et al. (1994) and Lavery et al. (2004), but contrary to Knabel et 
al. (1998) and Sinowatz et al. (2000) who applied a combination of Proteinase K and HCl to 
their cryosections. Obviously, no general recommendation can be made for cryosections with 
regard to deproteinisation. In fact, the importance of optimising the pretreatment for each 
single tissue type has been pointed out by other researchers (Singer et al., 1986; Yang et al., 
1999). The reason as to why strongest staining signals were achieved without deproteinising 
the sections cannot be completely clarified. Subjecting cryosections to 4% PFA for 15 min as 
used herein can be considered as a mild fixation with modest cross-linking between proteins 
and nucleic acids (Singer et al., 1986), thus leaving the target mRNA possibly still accessible 
to the probe. Increased cross-linking lowers the accessibility of the target sequence 
(Wilkinson, 1998). 
Size and homology of probe 
Clearly, longer probes can give stronger signals because more labelled nucleotides can be 
incorporated into them. In addition, the stability of the hybrid increases with the size of the 
probe (Wilkinson, 1998). However, the penetration of the tissue sections might diminish with 
increasing probe length. A probe length of 200 to 400 nt has been recommended for optimal 
penetration and signalling, while longer probes can be cleaved into shorter fragments by 
partial alkaline hydrolysis to simplify penetration (Wilkinson, 1998). However, Yang et al. 
(1999) found that RNA probes (up to 2600 nt) not only readily permeated cryosections, but 
also yielded stronger signals than hydrolysed probes of equivalent starting length. 
The introduction of a third probe, the longer homologous probe bHp2 with 302 nt, was crucial 
to the success of the present ISH method to localise Hp mRNA in bovine mammary gland. 
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Already in hepatocytes with their high abundance of Hp mRNA it was observed that neither 
the use of the shorter homologous bHp1 probe (174 nt), nor the heterologous, 338 nt long 
hHp2 probe achieved results as satisfying as with the bHp2 probe. The bHp1 probe, which 
was tested first, might have simply been too short to provide a sufficient number of DIG 
molecules for a strong ISH signal. According to Roche, the manufacturer of the DIG RNA 
labelling kit, every 20th to 25th nucleotide of the synthesised probe is DIG-UTP, i.e. bHp1 
contained only seven to nine DIG-UTP. For that reason, the longer, though heterologous 
probe hHp2 was tested next. However, no improvement in the signal intensity could be 
recognised, which might be explained by the alignment identities of 82% between the two 
known cDNA sequences of bHp and hHp and 81% between the known bHp sequence and the 
actual hHp probe sequence, respectively. The appendix illustrates the exact alignment of these 
bovine and human sequences. A total of 35 mismatches becomes obvious between the bHp 
cDNA sequence and the hHp probe sequence. Most of these mismatches, namely 31, are 
confined to 1 bp only, while the other gaps are of greater size. The longest gap segment 
stretches even over 8 bp (bHp cDNA sequence bp 119 to 126). It is worth noting that the 
initial 79 nt of the human Hp probe could not be aligned to the bovine Hp cDNA sequence 
since of the latter a length of only 302 bp is currently known (see Appendix for details). As a 
result of these mismatches, less stable hybrids are likely to have been produced between the 
human probe and the bovine Hp mRNA sequence in situ. Therefore, this might have caused 
the probe to become detached subsequently by stringent washes and RNase digest yielding 
inferior staining signals. Finally, the third probe, bHp2, was introduced yielding optimal 
staining results. This probe was not only homologous but also with 302 nt almost twice as 
long as bHp1 and even shorter than hHp. The specificity of this bHp2 probe was not tested in 
this study, however, homologous hybridisation of this probe to the bHp gene had previously 
been demonstrated with Northern analysis (Lavery et al., 2004).  
It must also be mentioned at this stage that another vital part of the established ISH protocol 
was the TSA system. The TSA system was added to the ISH protocol that already used the 
bHp2 probe; whether equally meaningful results would have been achieved in the bovine 
mammary gland by combining the TSA and the shorter bHp1 probe together in one protocol 
was not investigated.  
Posthybridisation washes 
A key component of the posthybridisation washes was the RNase digest, the aim of which is 
to increase signal specificity by reducing background noise. A number of concentrations and 
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combinations of two RNases (RNase A and RNase T1) were tested of which the application 
of 5 µg RNase A + 50 U RNase T1/ml for 30 min at 37°C was chosen. This was only half the 
concentrations used by Goldammer et al. (2004), but more than used by Yang et al. (1999). In 
fact, the latter researchers declared an RNase digest even as unnecessary, because they 
observed not only a considerably stronger hybridisation signal in sections without RNase 
digest, but most importantly non-specific background was not significantly reduced by RNase 
digest. While developing the current protocol for in situ localisation of Hp mRNA in the 
mammary gland, a loss of signal intensity was also frequently recognised when introducing an 
RNase digest as seen by Yang et al. (1999). Nevertheless, it was decided to maintain the 
RNase digest to ensure a high specificity of ISH signal.  
Amplification of hybridisation signal 
Two options of signal enhancers were tested: PVA as part of the substrate buffer and the 
tyramide signal amplification system. The alkaline phosphatase reaction with NBT/BCIP is 
relatively slow; reaction intermediates can diffuse into the medium and might not be available 
for the final precipitation of formazan. Hence, reduction of the signal can be the consequence 
(Van Noorden and Jonges, 1987). The addition of 10% PVA to the substrate buffer 
successfully enhanced this enzyme reaction resulting in a 20-fold increase in sensitivity (De 
Block and Debrouwer, 1993). However, no signal enhancement with 10% PVA in the 
substrate buffer could be demonstrated in this study which is why this option was not further 
pursued.  
In contrast, the addition of the signal amplification system TSA to the immunodetection 
process, the principle of which was introduced in chapter Materials and Methods, was crucial 
to the outcome of this experiment and finally produced the desired strong hybridisation 
signals for Hp mRNA in the mammary gland. A number of studies have applied this kind of 
signal enhancement for detection of low abundance mRNAs (Van de Corput et al., 1998; 
Yang et al., 1999; Evans et al., 2003; Karatsaidis et al., 2003), of which only the former study 
used tyramide conjugated to DNP instead of biotin. For this work also tyramide conjugated to 
DNP was purchased. The advantage of DNP over biotin labelling is that DNP is not an 
endogenous substance in mammalian tissue which could interfere with the specificity, 
whereas endogenous biotin of animal tissue has to be inactivated prior to detection to avoid 
such interference. A negative aspect of increased sensitivity by TSA is also a possible 
increase in background noise. In order to overcome this side effect the manufacturer 
suggested decreasing probe concentration. Indeed, Yang et al. (1999) found that high non-
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specific staining in lingual tissue with sense and antisense probe alike could be counteracted 
by reducing the probe concentration 10-fold. Although no major background signals were 
discovered after the introduction of the TSA system, a 10-fold lower probe concentration was 
also found to be sufficient in the current study. Incubation time of both antibodies, 
Anti-DIG-POD and Anti-DNP-AP, was prolonged from 30 min recommended by the 
manufacturer to 1 h as established by Yang et al. (1999) with the idea to further amplify 
hybridisation signal, in particular in mammary sections from Staph. aureus cows. 
EnVision+, a two-layer dextran polymer visualisation system, was also considered when 
choosing a means of signal amplification. Wiedorn et al. (2001) reported that this method, 
although superior to conventional ISH, did not achieve the same sensitivity as the TSA-biotin 
system. Therefore, the TSA based signal enhancement was preferred.  
Sensitivity of the ISH method applied 
While Hp mRNA in epithelium cells could clearly be detected by the chosen ISH method, this 
was surprisingly not the case for leukocytes in the mammary gland. These cells typically 
infiltrate healthy and, in markedly higher numbers, infected udders (Frost et al., 1982; 
Gudding et al., 1984). The two cells stained in the stroma of the E. coli cow (Figure 3.10; B1, 
B2) are too few to represent leukocytes since a higher number of them can be expected within 
an infected gland. This lack of ISH signal is in contrast to the results of the first investigation 
in this current study identifying Hp mRNA in isolated bovine peripheral blood leukocytes and 
milk somatic cells and might be explained by an insufficient sensitivity of the ISH method 
applied. Lavery et al. (2004) failed to detect Hp mRNA in bovine oviduct by in situ 
hybridisation using radioactive probes and even the same probe sequence, yet revealed a 
positive signal by Northern blotting. Jin and Lloyd (1997) pointed out that a detection limit of 
non-radioactive ISH was 20 transcripts/cell, though Femino et al. (1998) managed to visualise 
even a single RNA transcript by fluorescence ISH. It is not known how many Hp mRNA 
transcripts are commonly present in leukocytes, in particular in polymorphonuclear 
granulocytes. Real-time RT-PCR analysis of these cells would be a tool to quantify that 
further. 
On the other hand, sensitivity could be improved by increasing probe length. However, the 
limiting factor for increasing the length of the bHp probe is the current knowledge of the 
bovine partial Hp cDNA sequence of only 302 bp equalling the probe length used. Complete 
sequences of cDNA could be yielded by rapid amplification of cDNA ends (RACE). This is a 
PCR-based technique which was developed to facilitate the cloning of full-length cDNA 5'- 
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and 3'-ends after a partial cDNA sequence has been obtained by other methods (Schaefer, 
1995). 
ISH controls 
Both controls worked successfully: Hp mRNA in bovine liver as well as casein mRNA in 
bovine mammary gland could be localised by ISH. Thus, it could be documented that on the 
one hand Hp mRNA could principally be visualised by chosen ISH conditions and, on the 
other hand, in situ localisation of an mRNA in the mammary gland was possible. Both 
protocols, in contrast to Hp mRNA detection in the mammary gland, could be applied without 
the introduction of signal amplification reflecting the high abundance of each kind of mRNA 
in the respective organ. However, one important difference between the two protocols is the 
additional deproteinisation with Proteinase K and HCl in the ISH for casein mRNA. While 
the exclusion of deproteinisation was crucial for the Hp mRNA analysis as mentioned before, 
this omission was tested only after the protocol for casein mRNA had been validated. 
Therefore, the actual importance of deproteinisation of mammary gland sections to detect 
casein mRNA cannot be resolved. Whether the greater length of the casein antisense probe 
(750 nt) compared to the Hp probes played a role in requiring this extra permeabilisation step 
was not in the interest of this study. 
4.2 Discussion of the results obtained 
Hp mRNA expression in bovine liver 
Hp mRNA expression was detected by ISH in bovine hepatocytes, supporting the general 
view that the liver is the main site of Hp synthesis (Miller et al., 1951). Moreover, it confirms 
the findings by Lavery et al. (2004) who similarly applied the ISH method to detect Hp 
mRNA in bovine liver, although they used autoradiographic instead of chromogenic ISH. The 
staining observed in the present study was uniform throughout the liver lobules. While this is 
in contrast to the predominant expression of Hp mRNA in the periportal region as seen in 
mice (Peters et al., 1997), it might reflect a species difference between cattle and mouse. 
Since the specificity of the bHp2 probe used was tested by Northern analysis previously 
(Lavery et al., 2004), it can be excluded that the staining of hepatocytes was unspecific. 
Further "fine tuning" of the ISH method with reduced amount of probe, hybridisation time or 
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substrate incubation time might clarify the existence of a possible gradient of Hp mRNA 
expression also throughout the bovine liver. 
Hp mRNA expression in blood leukocytes, milk somatic cells and mammary gland 
This study allocates Hp mRNA expression to circulating leukocytes, milk somatic cells and 
mammary epithelial cells in cattle which specifies novel sites of Hp gene expression in this 
species not previously reported in the literature. However, Hp mRNA expression outside the 
liver is not unknown, but has been verified in a variety of tissues in bovines and other 
mammals as outlined in the introduction. In particular, the presence of Hp mRNA was 
demonstrated in human epidermal keratinocytes and endometrium (Sharpe-Timms et al., 
2000; Li et al., 2005), representing different kinds of epithelial cells. This underlines that 
epithelial cells are capable of Hp gene expression and supports the current finding of Hp 
mRNA in the epithelium of the bovine mammary gland. Moreover, it has been established 
that mammary epithelial cells can transcribe IL-6 in vitro (Okada et al., 1997; Pareek et al., 
2005), the main cytokine known to be in charge of inducing Hp gene expression in bovine 
hepatocytes (Yoshioka et al., 2002). In fact, the study by Pareek et al. (2005) demonstrated 
even a 10-fold increase of IL-6 mRNA abundance 6 h after LPS challenge. The precise 
regulation of Hp gene expression in the bovine mammary gland is not known, however, if it 
also required a cytokine stimulus as in liver, these latter studies would further emphasize the 
specificity of the ISH signals for Hp mRNA in the mammary epithelium obtained in the 
present experiment, particularly seen in sections from cows with E. coli infection.  
Besides Hp mRNA expression, also the expression of other APPs is well recognised in the 
bovine mammary gland epithelium, e.g. lactoferrin, mammary-associated-SAA 3 and 
mammary SAA 3 homologue (Molenaar et al., 1996; McDonald et al., 2001; Molenaar et al., 
2002).  
Hp mRNA expression detected in bovine leukocytes is in agreement with one human study 
reporting on Hp mRNA expression in eosinophils (Yang et al., 2000). Similarly, lymphocytes, 
monocytes and plasma cells express mRNA of another APP, namely SAA, though this again 
was proven only in humans or human cell lines (Ray and Ray, 1997; Urieli-Shoval et al., 
1998). The Hp mRNA expression discovered in bovine milk somatic cells confirms the 
present results obtained for the blood cells as well as mammary epithelial cells of this species, 
since milk somatic cells generally comprise more than 90% blood-derived cells next to 
epithelial cells exfoliated from mammary epithelium (Harmon, 1994; Boutinaud and Jammes, 
2002). 
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Most importantly, this cellular localisation of Hp gene expression advances the recent finding 
of Hp mRNA in homogenates of the bovine udder (Hiss et al., 2004). Their method did not 
allow to distinguish between different cell types expressing Hp mRNA. The current study 
clearly specified possible sites of Hp mRNA synthesis in the mammary gland as epithelium 
cells of the gland itself as well as immune cells of the blood. 
The effects of intramammary infection and type of pathogen on the transcript level of Hp 
detected in the mammary gland by ISH will be discussed below. 
In humans, Hp mRNA was detected in isolated leukocytes. These latter results varied between 
individuals. Moreover, Hp specific bands were seen only after reamplification of first course 
PCR products. The lack of Hp mRNA in human leukocytes by our standard RT-PCR method, 
though in contrast to bovines, is in agreement with results from the less sensitive Northern 
Blot analysis of human blood cells by Wagner et al. (1996). However, the presence of Hp 
specific transcripts after reamplification of the first course PCR products in two out of four 
individuals might reflect a weak Hp gene expression in human leukocytes. Even in the cells of 
the fourth subject a distinct signal of Hp specific PCR products was observed after 
reamplification despite a reduced intensity of the band of the housekeeping gene β-actin. 
Yang et al. (2000) detected Hp mRNA in circulating eosinophils of healthy donors by ISH, 
but not in other blood cells. Eosinophils typically comprise only around 2% of total 
leukocytes in healthy individuals (Klinke and Silbernagel, 1994). The differential cell count 
of the four test persons in this current work revealed 1-3% eosinophils of total leukocytes, 
thus all being close to the normal values. Therefore, the fact that only a minority of leukocytes 
appear to exhibit Hp mRNA expression, might explain the extremely low levels observed in 
the present samples.  
The current study identified Hp mRNA not only in extracts of the human mammary gland but 
is also the first study to report on Hp mRNA expression in this organ. This finding is in 
accordance with Hiss et al. (2004) who showed the equivalent for cows. Clearly, standard RT-
PCR results cannot be compared in absolute terms. However, given the low abundance of Hp 
mRNA in human leukocytes as determined by PCR in contrast to the strong PCR signal in the 
human mammary gland, this might be interpreted as an indication of Hp mRNA synthesis 
locally within this gland. As shown within this study for cows, alveolar epithelium cells are 
possible candidates. Gene expression of another acute phase protein, namely SAA, in normal 
human breast epithelium could already be established (Urieli-Shoval et al., 1998). 
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Nevertheless, here still remains the task to identify the exact cell type of Hp mRNA 
expression which is possible via ISH. 
Hp mRNA expression: bovine vs. human leukocytes 
The difference observed between cattle and man in the abundance of Hp transcripts in 
leukocytes, as determined by PCR amplification and reamplification, might be explained by 
two main factors: methodical or species differences. On the one hand, species specific PCR 
primers were applied to the samples of bovine and human origin. While primers have an 
effect on the PCR amplification rate (Cuypers et al., 1992), nothing is known about the 
efficiency of the two primer pairs bHp1 and hHp applied in this current leukocyte analysis. 
Hence, their PCR results cannot be compared quantitatively in a precise manner. On the other 
hand, a strong band for the human liver control was visualised by gel electrophoretic 
resolution, the intensity of which was similar to the signal intensity of the bovine liver and 
even bovine blood cell samples. From this might be speculated that the entire absence of first 
course PCR products and the presence of reamplification products in only 50% of the 
leukocyte samples of the examined individuals might indeed reflect a lower abundance of Hp 
mRNA in these human cells and, thus, a species difference between man and cattle regarding 
Hp mRNA presence in circulation leukocytes. This difference of Hp mRNA abundance could 
be determined by a generally lower expression rate, but similar degradation rate of Hp mRNA 
or, alternatively, by a similar expression rate, but higher degradation rate in humans compared 
to bovines. Quantitative real-time RT-PCR might elucidate this possible difference further, 
although not identical primer pairs applied to bovine and human samples would again be a 
limiting factor for proper comparison. Despite these uncertainties, a well known difference 
between cattle and man exists concerning the acute phase protein Hp. In cattle, Hp is 
considered to be one of the most prominent indicators of inflammation (Eckersall and Conner, 
1988), whereas in man the Hp blood concentration reacts only moderately to inflammation 
(Heinrich et al., 1990). Instead, CRP is the most sensitive APP in man (Heinrich et al., 1990). 
Effects of intramammary infection on local Hp mRNA expression as well as on Hp protein 
levels in blood and milk 
ISH with sections from intramammarily infected bovine udders revealed that the transcript 
level of Hp detected in each mammary gland quarter was remarkably influenced by type as 
well as duration of infection. The substantial rise in the abundance of Hp mRNA in mammary 
quarters during the progress of E. coli infection indicates a strong immune response by the 
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cow. This also confirms the changes of Hp mRNA expression found in mammary gland 
biopsies after E. coli-LPS intramammary challenge (Hiss et al., 2004). In that study, a first 
elevation of Hp mRNA transcripts was detected already 3 h post challenge, increasing further 
thereafter. In contrast, in Staph. aureus treated cows, no marked changes in Hp mRNA 
expression in the mammary gland could be recognised during the initial 24 h of infection, 
which could be interpreted in the way that these cows maintained their basal level of 
expression. No literature reporting on Hp mRNA in response to Staph. aureus intramammary 
infection could be sourced for comparison. However, mammary epithelium cells exposed in 
vitro 24 h to LPS responded with a significant 10-fold increase in SAA mRNA expression, in 
contrast to in vitro infection with Staph. aureus which caused no significant changes in SAA 
mRNA (Wellnitz and Kerr, 2004). The low expression of Hp mRNA observed herein in the 
control quarters of both treatment groups indicates a general basal level of Hp expression 
within the bovine mammary gland. Although an increase in Hp mRNA expression was 
noticed also in control quarters in the above mentioned study by Hiss et al. (2004), this 
elevation was attributed to a local immune response to biopsy sampling from those quarters.  
Similarly to the mRNA levels, E. coli and Staph. aureus exerted different effects also on Hp 
protein levels in both blood and milk. E. coli treatment led to substantially elevated mean Hp 
concentrations in both blood (55-fold) and particularly milk (165-fold), whereas Staph. 
aureus treatment caused only minimal changes (5-fold increase in blood Hp and no increase 
in milk Hp in one cow; negligible changes in blood and milk of the two other cows). The 
latter findings contradict results from another study involving dairy cows also experimentally 
infected with Staph. aureus into the mammary gland (Gronlund et al., 2003), which exhibited 
20-fold increases in blood as well as milk Hp levels. However, these researchers measured the 
first above normal values in blood and in milk only 24 h post-infection, and the peak values 
were reached after 72 h and 54 h, respectively. This suggests that in the present experiment 
the time period of the first 24 h post-inoculation might have been insufficiently long to 
comprise the entire immune response to Staph. aureus and, thus, might account for the lack of 
noticeable changes in Hp mRNA and protein levels. On the other hand, the early and 
significant immune response in terms of Hp protein concentration discovered in both blood 
and milk to E. coli intramammary infection is in accordance with the findings by Salonen et 
al. (1996) and Hiss et al. (2004) obtained from similar experimental intramammary 
challenges. Salonen et al. (1996), studying Hp levels only in blood, documented an elevation 
above normal values after 12 h and reaching the peak value 72 h post-challenge equalling to a 
52-fold total increase. More interestingly, Hiss et al. (2004) detected within hours not only a 
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significant change to basal values of blood concentration, but also a significant rise in milk 
Hp concentration following intramammary infection with E. coli-LPS. In fact, while in their 
study basal concentrations of blood and milk Hp were numerically similar to those in the 
current study, the respective values rose 10 and 150-fold after 12 h, but only less than 2 and 
20-fold in this current investigation after the same time. This stronger response might be due 
to their use of the endotoxin directly rather than the original bacterium E. coli or due to the 
use of a different E. coli strain for endotoxin extraction. 
These observed divergent effects of E. coli and Staph. aureus on Hp transcript and on protein 
levels in the mammary gland and in blood and milk, respectively, are consistent with general 
differences reported on the immune response to these two pathogens. Intramammary infection 
by E. coli is acute in nature, eliminated spontaneously by the cow and, thus, cured within a 
few days (Smith and Hogan, 1993; Hoeben et al., 2000). In contrast, while an infection with 
Staph. aureus can also start with an acute phase, it is mostly less severe and often becomes 
chronic and subclinical (Sutra and Poutrel, 1994). It was speculated that the latter effect might 
be due to an insufficient immune response to this pathogen (Sutra and Poutrel, 1994). A key 
component of the immune response is the upregulation of cytokine production in 
macrophages and endothelial cells (Dinarello, 2000; Arredouani et al., 2005). Subsequently, 
cytokines initiate not only the recruitment of leukocytes to inflammatory sites but also the 
enhanced synthesis of acute phase proteins as part of the acute phase response (Cybulsky et 
al., 1988; Ohtsuka et al., 2001; Yoshioka et al., 2002). Besides TNF-α, IL-1 and IL-6 already 
mentioned in the introduction, IL-8 is another important cytokine produced at higher rates 
during the immune response and mediates the transendothelial neutrophil migration (Huber et 
al., 1991). Therefore it is not surprising that studies applying intramammary infection models 
with E. coli and Staph. aureus demonstrated indeed differences in the level of blood and even 
milk cytokines. For instance, after intramammary infection with E. coli a strong and rapid 
concentration increase was detected of Hp protein in blood as well as of inflammatory 
cytokines in whey, such as TNF-α, IL-1β and IL-8, compared to only a moderate increase in 
Hp blood concentrations and even absence of detectable cytokines in milk in Staph. aureus 
infected animals (Riollet et al., 2001). Similarly, both E. coli and Staph. aureus 
intramammary infection induced increases in milk IL-1β levels, although with a delay in the 
Staph. aureus cows, but only E. coli elicited the production of TNF-α and IL-8 (Bannerman et 
al., 2004). In summary, these prominent differences in cytokine concentrations exerted by 
E. coli and Staph. aureus as seen in the previous two studies might account for the different 
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outcomes in Hp mRNA and protein levels analysed in the present study applying the same 
kinds of mastitis pathogens.  
Other elements involved in the immune response are Toll-like receptors (TLR) immediately at 
the beginning of signalling cascade. TLR are recognised as cell surface receptors located on 
phagocytes. After recognition of pathogens they initiate a signalling pathway to counteract 
these pathogens at the end of which stands the expression of certain genes, in particular of 
cytokines (Takeda and Akira, 2005). Different kinds of TLR come into play depending on the 
pathogen present. For example, TLR 2 is generally described as the essential receptors for 
components of Gram-positive bacteria (e.g. Staph. aureus) and TLR4 as the essential receptor 
of LPS as a major constituent of Gram-negative bacteria (e.g. E. coli) (Takeda and Akira, 
2005). However, Goldammer et al. (2004) reported that TLR 2 as well as TLR 4 increased 
simultaneously in bovine mammary glands during mastitis, but interestingly even markedly 
higher in glands infected with Staph. aureus compared to E. coli. These results are 
unexpected and do not fit in with the general findings on the immune response to E. coli and 
Staph. aureus mastitis.  
A weakness of this study is the limited knowledge of the actual virulence of the specific 
strains used in this trial and how representative they are for strains causing mastitis. Since 
they were isolated and cultured from clinical mastitis cases, it can be assumed that they cause 
clinical mastitis again after experimental reapplication into the mammary gland. Obviously, 
the severity of the disease is also dose dependant, but no general recommendation can be 
made. The current study used a dose of 500 and 10,000 cfu/quarter of E. coli and Staph. 
aureus, respectively, whereas Bannerman et al. (2004) achieved clinical mastitis with as little 
as 72 to 74 cfu/quarter of either bacteria type and yet observed significant variations in the 
immune response. Again other researchers applied 1500 cfu and 100,000 cfu/quarter of E. coli 
and Staph. aureus, respectively (Salonen et al., 1996; Gronlund et al., 2003). Hence, it is 
difficult to judge how representative the infection models used in this study are for E. coli and 
Staph. aureus mastitis. However, evaluating the Hp response during the progress of mastitis 
by applying the bacteria into the quarters of one mammary gland at different time points 
relative to slaughter is a valid model, as has been verified by other researchers (Frost et al., 
1982; Frost et al., 1984). Furthermore, the fact that the local immune response within the 
mammary gland remains confined to the affected quarter has been well established (Frost et 
al., 1984; Mehrzad et al., 2004). 
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Potential physiological benefits of local Hp expression in immune and mammary gland cells 
The physiological benefit of local Hp expression in immune and mammary epithelial cells 
and, in particular, the rapid availability of the protein in the mammary gland during infection 
might be manifold. One important characteristic of Hp is its down-regulation of the host 
immune response by acting on the circulating immune cells: Hp suppresses production of pro-
inflammatory, but not anti-inflammatory cytokines in monocytes, inhibits the respiratory burst 
activity in neutrophils and reduces lymphocyte proliferation as was shown in vitro (Baseler 
and Burrell, 1983; Oh et al., 1990; Arredouani et al., 2005). All these three functions of Hp 
might come into play also in the mammary gland, especially during E. coli infection where 
the rapid rise of Hp mRNA was observed. For instance, the presence of Hp in epithelial cells 
might allow the former effect to occur likewise in these cells capable of producing also the 
pro-inflammatory cytokines TNF-α and IL-1 (Okada et al., 1997). In fact, by producing 
simultaneously IL-6, the main inducer of Hp protein synthesis, these cells might exert an 
overall negative feedback on pro-inflammatory cytokine production within themselves. 
Furthermore, since the influx of neutrophils occurs already within a few hours after onset of 
intramammary infection, particularly E. coli infection, the almost immediate enhancement of 
local Hp production to encounter possible tissue damage caused by neutrophil respiratory 
burst activity might be advantageous over the supply delay resulting from systemic up-
regulation of Hp production in the liver. 
Another well known ability of Hp is to bind haemoglobin and thereby not only hampering the 
iron requiring process of bacterial replication as was shown for E. coli (Eaton et al., 1982), 
but also inhibiting oxidative damage caused by free haemoglobin (Miller et al., 1997). A 
bacteriostatic effect of Hp on Staph. aureus has yet to be defined. Red blood cells can appear 
in the milk of the inflamed quarters as a result of the dramatic alteration in mammary blood 
flow and microvascular integrity during mastitis (Vandeputte-Van Messom et al., 1993).  
Finally, Hp is able to promote tissue repair through stimulating angiogenesis as has been 
reported under chronic inflammatory conditions (Cid et al., 1993). Tissue damage is a feature 
often accompanying mastitis, in particular E. coli mastitis (Burvenich et al., 2003). 
 
 
 5 Conclusions 
The current study clearly identified novel sites of mRNA expression of the acute phase 
protein haptoglobin in cattle, namely circulating immune cells, milk somatic cells and 
epithelial cells of the mammary gland. Hp mRNA presence was verified even in both 
subpopulations of the peripheral blood cells examined: the mononuclear cells and the 
polymorphonuclear cells. In addition, besides generally assigning Hp mRNA expression in 
the mammary gland to the alveolar epithelium, it can be concluded from the experimental 
infection model that some mastitis pathogens are able to alter level of Hp mRNA expression 
in these cells. E. coli caused a marked upregulation of Hp mRNA expression within hours 
after start of infection, whereas Hp mRNA expression in response to Staph. aureus infections 
appeared unchanged over 24 h. These differences in mRNA presence were matched by Hp 
protein concentrations measured in blood and milk. Finally, Hp mRNA expression became 
evident in human leukocytes and human mammary gland. In conclusion, this study identified 
novel cellular sites of Hp mRNA expression in dairy cows and, thus, possible sources of the 
Hp protein found in milk. It also confirmed that Hp plays a role in the encounter of bacterial 
infections in the bovine mammary gland. However, the explicit significance of this local 
production and immediate availability of the protein have to be determined by future studies.  
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 7 Appendix 
7.1 Chemicals, solutions, consumables, instruments and 
software 
Chemicals 
Applichem, Darmstadt, Germany 
Agarose, boric acid, 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP), 
1-bromine-3-chlorine propane, 50x Denhardt's solution, diethylpyrocarbonate (DEPC), 
ethylenediaminotetraacetic acid disodium salt (EDTA), formamide deionised, isoamyl 
alcohol, 3-morpholinopropanesulfonic acid (MOPS), nitro blue tetrazolium (NBT), potassium 
chloride (KCl), Proteinase K, sodium acetate anhydrous, sodium chloride (NaCl), tri-sodium 
citrate dihydrate (3 Na-citrate * 2H2O) 
BD Biosciences, Heidelberg, Germany  
Human mammary gland total RNA 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
37% Formaldehyde, glacial acetic acid, glycerine, guanidiniumthiocyanate (GTC), hydrogen 
peroxide (H2O2), hydrochloric acid (HCl), isopropanol, lithium chloride (LiCl), magnesium 
chloride hexahydrate (MgCl2 * 6 H2O), 2-mercaptoethanol, phenol, potassium aluminium 
sulphate, sodium hydroxide (NaOH) pellets, Tris-hydroxymethyl aminomethane (Tris-Base), 
Tween®20 
Chroma-Gesellschaft, Münster, Germany 
Orange G 
Eurobio, Les Ulis Cedex B, France 
Ethidium bromide (10 mg/ml) 
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Fermentas, St. Leon-Rot, Germany 
Desoxynucleotides triphosphates (dNTP), DNA marker ΦX174 DNA/BsuRI (HaeIII), 
magnesium chloride (MgCl2), RevertAid™ M-MuLV reverse transcriptase and 5x reaction 
buffer, RiboLock™ Ribonuclease Inhibitor, RNase A, RNase T1, Taq DNA polymerase and 
10x Taq buffer with ammonium sulphate ((NH4)2SO4) 
Invitrogen, Karlsruhe, Germany 
Agarose, primer, random hexamers 
KMF Laborchemie Handels GmbH, Lohmar, Germany 
Ethanol denatured with 1% methyl ethyl ketones 
Merck Eurolab GmbH, Darmstadt, Germany 
Calcium chloride dihydrate (CaCl2 * 2 H2O), Mayer's hemalum solution, di-methyl sulfoxide 
(DMSO), Kaiser's glycerol gelatine, di-sodium hydrogen phosphate dihydrate (Na2HPO4 * 
2 H2O), potassium dihydrogen phosphate anhydrous (KH2PO4) 
Oxoid GmbH, Wesel, Germany 
Kochsalz-Tabletten für Bakteriologie 
PerkinElmer, LAS, Rodgau Jügesheim, Germany 
TSA Plus DNP AP kit 
Qiagen, Hilden, Germany 
QIAquick PCR-purification kit 
Roche Diagnostics GmbH, Mannheim, Germany 
Anti-Dig-AP Fab fragments, blocking reagent, DNase I and 10x reaction buffer, fish sperm 
DNA (10 mg/ml), DIG RNA labelling kit 
Ratiopharm GmbH, Ulm, Germany 
Heparin-Natrium-5000-ratiopharm (5000 IU/0.2 ml ampoule) 
Serva, Electrophoresis GmbH, Heidelberg, Germany 
Trypan Blue stain 
Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany 
Acetic anhydride, bromophenol blue solution saturated, dextran sulphate, Histopaque®-1077, 
di-methylformamide (DMF), lauroylsarcosine sodium salt, levamisole, maleic acid, 0.1% 
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Nuclear Fast Red in 5% aluminium sulphate, paraformaldehyde (PFA), polyvinyl alcohol 70-
100 kDa (PVA), primer, triethanolamine (TEA), yeast tRNA 
Vogel Medizinische Technik und Elektronik, Gießen, Germany 
Tissue Tek® O.C.T.™ Compound (Sakura) 
Buffers and solutions – general 
DEPC-treated H2O 
1000 ml ultra-pure H2O 
0.1% = 1 ml DEPC 
It was mixed thoroughly several times at room temperature, incubated under safety hood 
overnight and autoclaved. 
0.5 M EDTA 
0.5 M = 46.53 g EDTA 
ad 250 ml  ultra-pure H2O 
pH was adjusted to 8.0. Autoclaved. 
0.9% NaCl 
0.9 % = 2 tablets NaCl  
ad 1000 ml ultra-pure H2O 
Autoclaved. 
10x PBS 
1.37 M = 80 g NaCl  
0.027 M = 2 g KCl  
0.015 M = 2 g KH2PO4 anhydrous  
0.096 M = 15 g Na2HPO4 * 2 H2O  
ad 1000 ml  ultra-pure H2O 
pH was adjusted with NaOH to 7.4. Buffer was treated with 0.1% (1 ml) DEPC as above 
and autoclaved. 
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1x PBS 
100 ml 10x PBS 
900 ml ultra-pure H2O 
For in situ hybridisation buffer was treated with 0.1% (1 ml) DEPC as above and 
autoclaved. 
2x PBS 
200 ml 10x PBS 
800 ml ultra-pure H2O 
80% Ethanol for cleaning 
800 ml  100% Ethanol, denatured  
200 ml ultra-pure H2O 
Ultra-pure H2O 
Water, pre-purified by reverse osmosis, was further purified by ion exchange resins to a 
resistivity of 18.2 MΩ*cm, photo-oxidised (185 nm) and ultra-filtered (0.2 µm) (Elga 
Labwater USF PureLab Plus UV/UF). Finally, this water was autoclaved. 
Buffers and solutions for RNA extraction, RT-PCR and gel 
electrophoreses 
1-Bromine-3-chlorine propane 
48 ml 1-Bromine-3-chlorine propane 
1 ml Isoamyl alcohol 
Stored at 4°C. 
5x DNA loading buffer 
50 mg  Orange G 
2 ml Glycerine 
400 ml 0.5 M EDTA, pH 8.0 
ad 10 ml  ultra-pure H2O 
Aliquots were stored at -20°C and 4°C long term and short term, respectively. 
Ethidium bromide, 1 mg/ml 
Ethidium bromide (10 mg/ml) was diluted 1:10 in DEPC-treated H2O. 
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GTC stock solution 
4 M = 47.26 g  GTC  
Some DEPC-treated H2O was added. 
25 mM = 3.33 ml 0.75 M Na-citrate, pH 7.0  
0.5% = 5 ml 10% (w/v) Lauroylsarcosine sodium salt  
75 ml DEPC-treated H2O 
The reagents were solved, if necessary by heating to 50°C. 
ad 100 ml DEPC-treated H2O 
Stored at 4°C for up to three months. 
GTC working solution 
100 ml  GTC stock solution 
780 µl  2-Mercaptoethanol 
Stored at 4°C up to one month. 
10% (w/v) Lauroylsarcosine sodium salt 
10% = 5g Lauroylsarcosine sodium salt 
ad 50 ml ultra-pure H2O 
10x MOPS buffer 
0.2 M = 41.8 g MOPS 
800 ml  ultra-pure H2O 
pH was adjusted to 7.0. 
50 mM = 16.6 ml 3 M Na-acetate  
10 mM = 20 ml 0.5 M EDTA, pH 8.0 
ad 1000 ml ultra-pure H2O 
Autoclaved and stored at room temperature protected from light. 
2 M Na-acetate 
2 M =16.4 g Sodium acetate, anhydrous 
40 ml Glacial acetic acid  
Heated to 40°C and pH adjusted to 4.0. 
ad 100 ml DEPC-treated H2O 
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3 M Na-acetate 
3 M = 24.6 g Sodium acetate, anhydrous  
ad 100 ml ultra-pure H2O 
No pH adjustment. 
0.75 M Na-citrate 
0.75 M = 22.06 g 3-Na-citrate * 2 H2O 
ad 100 ml DEPC-treated H2O 
pH was adjusted to 7.0.  
5x RNA loading buffer 
226 µl Bromophenol blue solution saturated 
20 µl 0.5 M EDTA, pH 8.0 
25 µl Ethidium bromide (10 mg/ml) 
180 µl 37% Formaldehyde 
500 µl 100% Glycerine  
771 µl Formamide, deionised  
1000 µl 10x MOPS buffer 
Aliquots were stored at 4°C for up to three months. 
10x TBE buffer 
890 mM = 108 g Tris-Base  
890 mM = 55 g Boric acid  
20 mM = 40 ml 0.5 M EDTA, pH 8.0 
ad 1000 ml ultra-pure H2O 
Autoclaved and stored at room temperature. 
Buffers and solutions for in situ hybridisation 
BCIP (50 mg BCIP/ml DMSO) 
300 mg BCIP  
ad 6 ml DMSO 
Aliquots were stored at -20°C and 4°C long term and short term, respectively, protected 
from light. Working aliquot was brought to room temperature prior to usage, since 
DMSO freezes at 4°C. 
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10% Blocking Reagent 
10% = 20 g Blocking reagent  
150 ml MA buffer 
Mixture was brought to boil thrice in microwave and stirred gently in between. After 
cooling down to room temperature:  
ad 200 ml MA buffer 
Solution was autoclaved and aliquots were stored at -20°C. 
1 M CaCl2 
1 M = 14.7 g CaCl2*2H2O 
ad 100 ml DEPC-treated H2O 
Autoclaved. 
50% Dextran sulphate 
50% = 2 g  Dextran sulphate  
2.5 ml DEPC-treated H2O 
This was left to dissolve overnight.  
ad 4 ml DEPC-treated H2O 
This was always prepared fresh in a 25 ml measuring cylinder one day prior to 
preparation of hybridisation buffer. 
DNP amplification reagent stock solution 
DNP amplification reagent (TSA Plus DNP AP kit) reconstituted in 0.3 or 0.15 ml 
DMSO, depending on kit size. Stored at 4°C. 
0.2 M HCl 
16.56 ml  37% HCl 
ad 1000 ml DEPC-treated H2O 
Not autoclaved. 
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Hybridisation buffer, 20 ml 
To 
10% = 4 ml 50% Dextran sulphate 
was added the following: 
150 mM = 1200 µl 2.5 M NaCl 
50% =10 ml Formamide, deionised 
2x = 2 ml 20x SSC 
0.2 mg/ml = 400 µl 10 mg/ml yeast tRNA 
1x = 400 µl 50x Denhardt's solution 
1 mg/ml = 2 ml  10 mg/ml Fish sperm DNA 
This was mixed thoroughly and left to stay until air bubbles had disappeared. Aliquots 
(1 ml) were stored at -20°C. 
4 M LiCl 
4 M = 16.96 g LiCl 
ad 100 ml ultra-pure H2O 
Solution was treated with 0.1% (100 µl) DEPC as above and autoclaved. 
MA buffer 
100 mM = 11.61 g MA 
150 mM = 8.77 g NaCl 
pH was adjusted to 7.5 with NaOH pellets and 5 M NaOH. 
ad 1000 ml ultra-pure H2O 
Autoclaved. 
2.5 M NaCl 
2.5 M = 14.61 g NaCl 
ad 100 ml ultra-pure H2O 
Solution was treated with 0.1% (100 µl) DEPC as above and autoclaved. 
NBT (75 mg NBT/ml 70% DMF) 
300 mg NBT 
ad 4 ml 70% DMF 
Aliquots were stored at -20°C and 4°C long term and short term, respectively, protected 
from light.  
 
Appendix 89
4% (w/v) PFA 
10 g PFA 
220 ml 1x PBS 
This was brought to 65°C under ventilation hood and then 5 µl 5 M NaOH was added 
for the solution to become clear. If necessary, the solution was left at 65°C for 30 to 
60 min until PFA was completely dissolved. After cooling to room temperature, pH was 
adjusted to 7.3.  
ad 250 ml 1x PBS 
Stored protected from light and used within two weeks (preferably prepared fresh). 
Proteinase K (20 mg/ml) 
20 mg  Proteinase K  
1 ml DEPC-treated H2O 
Aliquots were stored at -20°C and after thawing once not reused.  
PVA substrate buffer 
10% = 10 g PVA 
90 ml Substrate buffer 1 
It was dissolved at 90°C and brought again to room temperature: 
ad 100 ml Substrate buffer 1 
RNA dilution buffer 
5 ml DEPC-treated H2O 
3 ml 20x SSC 
2 ml  37% Formaldehyde  
Aliquots were stored at -20°C.  
20x SSC 
3 M = 87.66 g NaCl  
0.3 M = 44.12 g 3 Na-citrate * 2H2O  
ad 500 ml  ultra-pure H2O 
pH was adjusted to 7.0. Solution was treated with 1% (500 µl) DEPC as above and then 
autoclaved. 
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2x SSC 
20x SSC was diluted 1:10 in DEPC-treated H2O or ultra-pure H2O for work pre- or post- 
hybridisation, respectively. 
Substrate buffer 1 
100 mM = 12.1 g  Tris-Base  
100 mM = 5.84 g NaCl  
pH was adjusted to 9.5 with 5 M HCl. 
ad 1000 ml  ultra-pure H2O 
Autoclaved. 
Substrate buffer 2 
100 mM = 12.1 g  Tris-Base  
100 mM = 5.84 g NaCl  
800 ml ultra-pure H2O 
pH was adjusted to 9.5 with 5 M HCl. 
50 mM = 10.16 g MgCl2 * 6 H2O 
ad 1000 ml  ultra-pure H2O 
Buffer was filtered sterilize. It was not autoclaved to avoid Mg-precipitates. 
0.1 M TEA buffer 
0.1 M = 13.2 ml TEA 
900 ml  DEPC-treated H2O 
pH was adjusted to 8.0 with 37% HCl. 
ad 1000 ml DEPC-treated H2O 
Autoclaved and stored at room temperature protected from light. 
TE buffer 
10 mM = 5 ml 1 M Tris-HCl 
1 mM = 1 ml 0.5 M EDTA 
pH was adjusted to 8.0. 
ad 500 ml ultra-pure H2O 
Autoclaved. 
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TN buffer 
0.1 M = 12.11g Tris-Base  
0.15 M = 8.77 g NaCl  
pH was adjusted to 7.5 with 37% HCl. 
ad 1000 ml ultra-pure H2O 
TNB blocking buffer 
0.5% = 0.5 g Blocking reagent (TSA Plus DNP AP kit) 
100 ml TN buffer 
Blocking reagent was added slowly in small increments to TN buffer while stirring and, 
if necessary, heated to 60°C to dissolve completely. Aliquots were stored at -20°C. 
TNT wash buffer 
0.05% = 2.5 ml 10% Tween 20 
497.5 ml TN buffer 
1 M Tris-HCl 
1 M = 60.57 g Tris-Base 
pH was adjusted to 8.0 with 37% HCl. 
ad 500 ml DEPC-treated H2O 
Autoclaved. 
Yeast tRNA (10 mg/ml) 
25 mg = 500 units Yeast tRNA  
2500 µl DEPC-treated H2O 
tRNA was dissolved by incubating on ice for at least 1 h. Aliquots were stored at -20°C. 
Important consumables 
Amersham Pharmacia Biotech, Uppsala, Sweden 
Nylon membrane Hybond-N+ 
Carl-Roth, Karlsruhe, Germany 
Hellendahl jars, Rotilabo®-Probenröhrchen (7 ml sample vial) 
Menzel-Gläser, Braunschweig, Germany 
SuperFrost® Plus microscope slides 
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Sigma, Taufenkirchen, Germany 
Hybri-Slips (40 mm x 24 mm) 
Zytomed, Berlin, Germany 
PAP Pen Super 
Main instruments 
Autoclave Systec-Table Autoklave, Model 2540 EL, Tuttnauer, Breda, The 
Netherlands 
Camera Polaroid DMC Ie, Cambridge, MA, USA 
Centrifuge Beckman CL-GPKR (swing out rotor), Munich, Germany 
Centrifuge Biofuge primo R, Heraeus Instruments GmbH, Osterode, 
Germany 
Centrifuge 1K15, Sigma, Taufkirchen, Germany 
Cryostat CM 3050 S, Leica, Nussloch, Germany 
Fluor Imager SI Amersham Pharmacia Biotech, Uppsala, Sweden 
HeizThermoMixer HTM 130 RP, HLC, Haep Labor Consult, Bovenden, Germany 
Microscope DM LB, Leica, Wetzlar, Germany 
Microscope Routine microscope, Axioskop 2 MOT, Zeiss, Jena, Germany  
pH Meter Orion, ORI037002, pH/mV/ISE/Temp Meter, Colora, Lorch, 
Germany 
Shaker 3005, Gesellschaft für Labortechnik (GFL), Burgwedel, Germany 
Spectrophotometer U-2000/1 Hitachi UV/VIS-Computer-Double-Beam-
Spectrophotometer, Colora, Lorch, Germany 
Thermocycler MJ Research, Biozym Diagnostik, Oldendorf, Germany 
Thermocycler Trio-Thermocycler V2.23© Biotron 190, Biometra, Göttingen, 
Germany 
Ultra Turrax T25, IKA Labortechnik, Staufen, Germany 
UV lamp  TCP-20.M Vilbert Lourmat, Marne-la-Vallée Cedex 1, France 
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Water purifier Elga Labwater, PureLab Plus™ UV/UF, Celle, Germany 
Software 
BLAST programme http://www.ncbi.nlm.nih.gov/BLAST/ 
(Altschul et al., 1990) 
Peak Finder ImageQuaNT™, Version 4.1, Molecular Dynamics, Amersham 
Pharmacia Biotech, Uppsala, Sweden 
Statistics programme  SPSS 12.0, Chicago, Illinois, USA 
Volume Report ImageQuaNT™, Version 4.1, Molecular Dynamics, Amersham 
Pharmacia Biotech, Uppsala, Sweden 
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7.2 Hp cDNA sequences and alignment 
Partial bovine Hp cDNA sequence 
Source: PubMed, Nucleotide, accession number: AJ 271156 
bHp1 primers in bold embracing 174 nt (33-206 nt): 
     1 ccaaaggcag ctttccttgg caggccaaga tggtctccca gcataacctc atctcgggag 
    61 ccacgctcat caatgaacga tggctcctca ccacagctaa aaatctctac ctgggtcaca 
   121 gtagtgacaa aaaagcaaag gacatcactc ctactttaag actctatgtg gggaagaacc 
   181 agcttgtaga ggtggagaag gtggttctcc accctgacca ctccaaggta gacattgggc 
   241 tcatcaaact cagacagaag gtacctgtca atgacaaagt aatgcccatc tgcctacctt 
   301 cc 
 
 
bHp2 primers in bold embracing 302 nt (1-302 nt): 
     1 ccaaaggcag ctttccttgg caggccaaga tggtctccca gcataacctc atctcgggag 
    61 ccacgctcat caatgaacga tggctcctca ccacagctaa aaatctctac ctgggtcaca 
   121 gtagtgacaa aaaagcaaag gacatcactc ctactttaag actctatgtg gggaagaacc 
   181 agcttgtaga ggtggagaag gtggttctcc accctgacca ctccaaggta gacattgggc 
   241 tcatcaaact cagacagaag gtacctgtca atgacaaagt aatgcccatc tgcctacctt
   301 cc 
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Partial human Hp cDNA sequence 
Source: PubMed, Nucleotide, accession number: NM_005143 
hHp primers in bold embracing 338 nt (471-808 nt): 
     1 agatgcccca cagcactgct cttccagagg caagaccaac caagatgagt gccctgggag 
    61 ctgtcattgc cctcctgctc tggggacagc tttttgcagt ggactcaggc aatgatgtca 
   121 cggatatcgc agatgacggc tgcccgaagc cccccgagat tgcacatggc tatgtggagc 
   181 actcggttcg ctaccagtgt aagaactact acaaactgcg cacagaagga gatggagtat 
   241 acaccttaaa tgataagaag cagtggataa ataaggctgt tggagataaa cttcctgaat 
   301 gtgaagcaga tgacggctgc ccgaagcccc ccgagattgc acatggctat gtggagcact 
   361 cggttcgcta ccagtgtaag aactactaca aactgcgcac agaaggagat ggagtgtaca 
   421 ccttaaacaa tgagaagcag tggataaata aggctgttgg agataaactt cctgaatgtg
   481 aagcagtatg tgggaagccc aagaatccgg caaacccagt gcagcggatc ctgggtggac 
   541 acctggatgc caaaggcagc tttccctggc aggctaagat ggtttcccac cataatctca 
   601 ccacaggtgc cacgctgatc aatgaacaat ggctgctgac cacggctaaa aatctcttcc 
   661 tgaaccattc agaaaatgca acagcgaaag acattgcccc tactttaaca ctctatgtgg 
   721 ggaaaaagca gcttgtagag attgagaagg ttgttctaca ccctaactac tcccaggtag 
   781 atattgggct catcaaactc aaacagaagg tgtctgttaa tgagagagtg atgcccatct 
   841 gcctaccttc aaaggattat gcagaagtag ggcgtgtggg ttatgtttct ggctgggggc 
   901 gaaatgccaa ttttaaattt actgaccatc tgaagtatgt catgctgcct gtggctgacc 
   961 aagaccaatg cataaggcat tatgaaggca gcacagtccc cgaaaagaag acaccgaaga 
  1021 gccctgtagg ggtgcagccc atactgaatg aacacacctt ctgtgctggc atgtctaagt 
  1081 accaagaaga cacctgctat ggcgatgcgg gcagtgcctt tgccgttcac gacctggagg 
  1141 aggacacctg gtatgcgact gggatcttaa gctttgataa gagctgtgct gtggctgagt 
  1201 atggtgtgta tgtgaaggtg acttccatcc aggactgggt tcagaagacc atagctgaga 
  1261 actaatgcaa ggctggccgg aagcccttgc ctgaaagcaa gatttcagcc tggaagaggg 
  1321 caaagtggac gggagtggac aggagtggat gcgataagat gtggtttgaa gctgatgggt 
  1381 gccagccctg cattgctgag tcaatcaata aagagctttc ttttgaccca ttt 
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Alignment of bovine and human Hp cDNA sequences 
Source: PubMed, Basic local alignment search tool (BLAST) (Altschul et al., 1990) 
Identities = 248/301 (82%) 
The fragment contained in the hHp probe is set in bold, i.e. 259 nt of the hHp2 probe (base 
550 to 808) can be aligned to the currently known bovine cDNA sequence. Identities = 
212/259 (81%). The starting sequence (79 nt) of the hHp2 probe (base 470 to 549) cannot be 
aligned to the bHp cDNA sequence due to the limited current knowledge of the latter. 
                                                                             
bHp:  1   ccaaaggcagctttccttggcaggccaagatggtctcccagcataacctcatctcgggag 60 
          |||||||||||||||| |||||||| |||||||| ||||| ||||| |||| | | || | 
hHp:  550 ccaaaggcagctttccctggcaggctaagatggtttcccaccataatctcaccacaggtg 609 
 
bHp:  61  ccacgctcatcaatgaacgatggctcctcaccacagctaaaaatctctacctgggtcaca 120 
          ||||||| |||||||||| |||||| || ||||| ||||||||||||| ||||   ||   
hHp:  610 ccacgctgatcaatgaacaatggctgctgaccacggctaaaaatctcttcctgaaccatt 669 
 
bHp:  121 gtagtgacaaaaaagcaaaggacatcactcctactttaagactctatgtggggaagaacc 180 
                |   || ||| || |||||  | |||||||||| ||||||||||||||| || | 
hHp:  670 cagaaaatgcaacagcgaaagacattgcccctactttaacactctatgtggggaaaaagc 729 
 
bHp:  181 agcttgtagaggtggagaaggtggttctccaccctgaccactccaaggtagacattgggc 240 
          ||||||||||| | |||||||| ||||| |||||| || ||||| ||||||| ||||||| 
hHp:  730 agcttgtagagattgagaaggttgttctacaccctaactactcccaggtagatattgggc 789 
 
bHp:  241 tcatcaaactcagacagaaggtacctgtcaatgacaaagtaatgcccatctgcctacctt 300 
          |||||||||||| |||||||||  |||| ||||| | ||| ||||||||||||||||||| 
hHp:  790 tcatcaaactcaaacagaaggtgtctgttaatgagagagtgatgcccatctgcctacctt 849 
 
bHp:  301 cc 302 
          | 
hHp:  850 ca 851 
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7.3 ISH protocols 
All steps were carried out in Hellendahl glass jars and at room temperature, unless stated 
otherwise. 
Detection of casein mRNA in bovine mammary gland 
Fixation and pretreatment 
• 12 µm cryosections 
 
• 4% PFA, 15 min 
• 1x PBS, 2 x 5 min 
 
• 50% ethanol, 5 min 
• 70% ethanol, 5 min 
• 90% ethanol, 5 min 
• 100% ethanol, 5 min 
• 90% ethanol (reusing the alcohol from above), 5 min 
• 70% ethanol (reusing the alcohol from above), 5 min 
• 50% ethanol (reusing the alcohol from above), 5 min 
• 1x PBS, 2 x 5 min 
 
• 10 µg Proteinase K/ml in 1x PBS, 10 min 
• 1x PBS, 2 x 5 min 
• 0.2 M HCl, 10 min 
 
• 0.1 M TEA + 0.25% acetic anhydride, 10 min 
• 2x SSC, 10 min 
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Hybridisation 
15 ng of casein probe (working solution 10 ng probe/µl DEPC-treated H2O) were mixed with 
hybridisation buffer up to a final volume of 50 µl, denatured at 80°C for 5 min and applied to 
each section. Hybridisation occurred in a humid chamber at 52°C overnight (16-18 h). 
Posthybridisation washes 
• 2x SSC, 2 x 10 min, 45°C 
• 50% formamide/50% 2x SSC, 10 min, 45°C 
• 50% formamide/50% 2x SSC, 20 min, 45°C 
• 0.2x SSC, 2 x 10 min, agitation (100 rpm) 
 
• 5 µg RNase A/ml + 50 U RNase T1/ml, 30 min, 37°C 
• 2x SSC, 3 x 10 min, agitation (100 rpm) 
Immunological detection 
• MA buffer, 10 min 
• 1% blocking solution in MA buffer, 30 min, agitation (100 rpm) 
• 100 µl Anti-Dig-AP antibody/section (not in glass jar), 1:500 diluted in MA buffer, 
2 h in humid chamber 
• 0.1% Tween in MA buffer, 15 min, agitation (100 rpm) 
• MA buffer, 3 x 15 min, agitation (100 rpm) 
• Substrate buffer 1, 10 min 
• Substrate (0.3375 mg NBT/ml + 0.175 mg BCIP/ml substrate buffer 1), incubated 
overnight protected from light 
• TE buffer, 10 min 
• Kaiser's glycerol gelatine for mounting 
Detection of Hp mRNA in bovine liver 
Fixation and pretreatment 
• 12 µm cryosections 
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• 4% PFA, 15 min 
• 1x PBS, 2 x 5 min 
 
• 0.1 M TEA + 0.25% acetic anhydride, 10 min 
• 2x SSC, 10 min 
 
Hybridisation 
30 ng of bHp2 probe (working solution 10 ng probe/µl DEPC-treated H2O) were mixed with 
hybridisation buffer up to a final volume of 50 µl, denatured at 80°C for 5 min and applied to 
each section. Hybridisation occurred in a humid chamber at 52°C overnight (16-18 h). 
Posthybridisation washes 
• 2x SSC, 2 x 10 min, 45°C 
• 50% formamide/50% 2x SSC, 10 min, 45°C 
• 50% formamide/50% 2x SSC, 20 min, 45°C 
• 0.2x SSC, 2 x 10 min, agitation (100 rpm) 
 
• 5 µg RNase A/ml + 50 U RNase T1/ml, 30 min, 37°C 
• 2x SSC, 3 x 10 min, agitation (100 rpm) 
Immunological detection 
• MA buffer, 10 min 
• 1% blocking solution in MA buffer, 30 min, agitation (100 rpm) 
• 100 µl Anti-Dig-AP antibody/section (not in glass jar), 1:500 diluted in MA buffer, 2 
h in humid chamber 
• 0.1% Tween in MA buffer, 15 min, agitation (100 rpm) 
• MA buffer, 3 x 15 min, agitation (100 rpm) 
• Substrate buffer 1, 10 min 
• Substrate (0.3375 mg NBT/ml + 0.175 mg BCIP/ml substrate buffer 1), incubated 
overnight protected from light 
• TE buffer, 10 min 
• Kaiser's glycerol gelatine for mounting 
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Detection of Hp mRNA in bovine mammary gland 
Fixation and pretreatment 
• 12 µm cryosections 
 
• 4% PFA, 15 min 
• 1x PBS, 2 x 5 min 
 
• 50% ethanol, 5 min 
• 70% ethanol, 5 min 
• 90% ethanol, 5 min 
• 100% ethanol, 5 min 
• 90% ethanol (reusing the alcohol from above), 5 min 
• 70% ethanol (reusing the alcohol from above), 5 min 
• 50% ethanol (reusing the alcohol from above), 5 min 
• 1x PBS, 2 x 5 min 
 
• 0.1 M TEA + 0.25% acetic anhydride, 10 min 
• 2x SSC, 10 min. 
Hybridisation 
3 ng of bHp2 probe (working solution 10 ng probe/µl DEPC-treated H2O) were mixed with 
hybridisation buffer up to a final volume of 50 µl, denatured at 80°C for 5 min and applied to 
each section. Hybridisation occurred in a humid chamber at 52°C overnight (16-18 h). 
Posthybridisation washes 
• 2x SSC, 2 x 10 min, 45°C 
• 50% formamide/50% 2x SSC, 10 min, 45°C 
• 50% formamide/50% 2x SSC, 20 min, 45°C 
• 0.2x SSC, 2 x 10 min, agitation (100 rpm) 
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• 5 µg RNase A/ml + 50 U RNase T1/ml, 30 min, 37°C 
• 2x SSC, 3 x 10 min, agitation (100 rpm). 
Immunological detection with TSA 
• TN buffer, 5 min 
• 100 µl TNB blocking buffer/section, 30 min 
• 90 µl Anti-DIG-POD antibody/section, diluted 1:100 in TNB buffer, 1 h in humid 
chamber protected from light 
• TNT wash buffer, 3 x 5 min, agitation (100 rpm) 
• 90 µl TSA Plus DNP working solution (DNP amplification reagent stock solution 
diluted 1:50 in 1x Plus Amplification diluent (TSA kit)), 10 min 
• TNT wash buffer, 3 x 5 min, agitation (100 rpm) 
• 90 µl Anti-DNP-AP/section, diluted 1:100 in TNB blocking buffer, 1 h in humid 
chamber protected from light 
• TNT wash buffer, 3 x 5 min, agitation (100 rpm) 
• Substrate buffer 1, 10 min 
• Substrate (0.3375 mg NBT/ml + 0.175 mg BCIP/ml substrate buffer 1), protected 
from light, 50 min 
• TE buffer, 10 min 
• Kaiser's glycerol gelatine for mounting. 
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